<?xml version="1.0" encoding="utf-8"?>
<!-- Copyright Â©2016 LexisNexis Univentio, The Netherlands. -->
<lexisnexis-patent-document schema-version="1.13" date-produced="20160127" file="US20150259602A1.xml" produced-by="LexisNexis-Univentio" lang="eng" date-inserted="20150917" time-inserted="030031" date-changed="20151002" time-changed="033556">
  <bibliographic-data lang="eng">
    <publication-reference publ-type="Application" publ-desc="Patent Application Publication">
      <document-id id="121313630">
        <country>US</country>
        <doc-number>20150259602</doc-number>
        <kind>A1</kind>
        <date>20150917</date>
      </document-id>
    </publication-reference>
    <application-reference appl-type="utility">
      <document-id>
        <country>US</country>
        <doc-number>14660172</doc-number>
        <date>20150317</date>
      </document-id>
    </application-reference>
    <application-series-code>14</application-series-code>
    <language-of-filing>eng</language-of-filing>
    <language-of-publication>eng</language-of-publication>
    <priority-claims date-changed="20150917">
      <priority-claim sequence="1" kind="national">
        <country>DE</country>
        <doc-number>102014003600</doc-number>
        <date>20140317</date>
      </priority-claim>
    </priority-claims>
    <dates-of-public-availability date-changed="20150924">
      <unexamined-printed-without-grant>
        <date>20150917</date>
      </unexamined-printed-without-grant>
    </dates-of-public-availability>
    <classifications-ipcr date-changed="20150924">
      <classification-ipcr sequence="1">
        <text>C09K  19/34        20060101AFI20150917BHUS        </text>
        <ipc-version-indicator>
          <date>20060101</date>
        </ipc-version-indicator>
        <classification-level>A</classification-level>
        <section>C</section>
        <class>09</class>
        <subclass>K</subclass>
        <main-group>19</main-group>
        <subgroup>34</subgroup>
        <symbol-position>F</symbol-position>
        <classification-value>I</classification-value>
        <action-date>
          <date>20150917</date>
        </action-date>
        <generating-office>
          <country>US</country>
        </generating-office>
        <classification-status>B</classification-status>
        <classification-data-source>H</classification-data-source>
      </classification-ipcr>
    </classifications-ipcr>
    <classifications-cpc date-changed="20150924">
      <classification-cpc sequence="1">
        <text>C09K  19/3405      20130101 FI20150917BHEP        </text>
        <cpc-version-indicator>
          <date>20130101</date>
        </cpc-version-indicator>
        <section>C</section>
        <class>09</class>
        <subclass>K</subclass>
        <main-group>19</main-group>
        <subgroup>3405</subgroup>
        <symbol-position>F</symbol-position>
        <classification-value>I</classification-value>
        <action-date>
          <date>20150917</date>
        </action-date>
        <generating-office>
          <country>EP</country>
        </generating-office>
        <classification-status>B</classification-status>
        <classification-data-source>H</classification-data-source>
      </classification-cpc>
      <classification-cpc sequence="2">
        <text>C07D 307/91        20130101 LI20150918BHEP        </text>
        <cpc-version-indicator>
          <date>20130101</date>
        </cpc-version-indicator>
        <section>C</section>
        <class>07</class>
        <subclass>D</subclass>
        <main-group>307</main-group>
        <subgroup>91</subgroup>
        <symbol-position>L</symbol-position>
        <classification-value>I</classification-value>
        <action-date>
          <date>20150918</date>
        </action-date>
        <generating-office>
          <country>EP</country>
        </generating-office>
        <classification-status>B</classification-status>
        <classification-data-source>H</classification-data-source>
      </classification-cpc>
      <classification-cpc sequence="3">
        <text>C09K2019/3408      20130101 LA20150917BHEP        </text>
        <cpc-version-indicator>
          <date>20130101</date>
        </cpc-version-indicator>
        <section>C</section>
        <class>09</class>
        <subclass>K</subclass>
        <main-group>2019</main-group>
        <subgroup>3408</subgroup>
        <symbol-position>L</symbol-position>
        <classification-value>A</classification-value>
        <action-date>
          <date>20150917</date>
        </action-date>
        <generating-office>
          <country>EP</country>
        </generating-office>
        <classification-status>B</classification-status>
        <classification-data-source>H</classification-data-source>
      </classification-cpc>
    </classifications-cpc>
    <number-of-claims calculated="yes">12</number-of-claims>
    <invention-title id="title_eng" date-changed="20150917" lang="eng" format="original">4,6-DIFLUORODIBENZOFURAN DERIVATIVES</invention-title>
    <parties date-changed="20150917">
      <applicants>
        <applicant sequence="1" app-type="applicant">
          <addressbook lang="eng">
            <orgname>MERCK PATENT GMBH</orgname>
            <role>03</role>
            <address>
              <city>Darmstadt</city>
              <country>DE</country>
            </address>
          </addressbook>
        </applicant>
      </applicants>
      <inventors>
        <inventor sequence="1" designation="us-only">
          <addressbook lang="eng">
            <last-name>REIFFENRATH</last-name>
            <first-name>Volker</first-name>
            <address>
              <city>Rossdorf</city>
              <country>DE</country>
            </address>
          </addressbook>
        </inventor>
        <inventor sequence="2" designation="us-only">
          <addressbook lang="eng">
            <last-name>BREMER</last-name>
            <first-name>Matthias</first-name>
            <address>
              <city>Darmstadt</city>
              <country>DE</country>
            </address>
          </addressbook>
        </inventor>
        <inventor sequence="3" designation="us-only">
          <addressbook lang="eng">
            <last-name>FORTTE</last-name>
            <first-name>Rocco</first-name>
            <address>
              <city>Frankfurt am Main</city>
              <country>DE</country>
            </address>
          </addressbook>
        </inventor>
        <inventor sequence="4" designation="us-only">
          <addressbook lang="eng">
            <last-name>HIRSCHMANN</last-name>
            <first-name>Harald</first-name>
            <address>
              <city>Darmstadt</city>
              <country>DE</country>
            </address>
          </addressbook>
        </inventor>
        <inventor sequence="5" designation="us-only">
          <addressbook lang="eng">
            <last-name>ENGEL</last-name>
            <first-name>Martin</first-name>
            <address>
              <city>Darmstadt</city>
              <country>DE</country>
            </address>
          </addressbook>
        </inventor>
      </inventors>
    </parties>
    <patent-family date-changed="20151130">
      <main-family family-id="173666136">
        <family-member>
          <document-id>
            <country>KR</country>
            <doc-number>1020150108325</doc-number>
            <kind>A</kind>
            <date>20150925</date>
          </document-id>
          <application-date>
            <date>20150316</date>
          </application-date>
        </family-member>
        <family-member>
          <document-id>
            <country>JP</country>
            <doc-number>2015174864</doc-number>
            <kind>A</kind>
            <date>20151005</date>
          </document-id>
          <application-date>
            <date>20150316</date>
          </application-date>
        </family-member>
        <family-member>
          <document-id>
            <country>DE</country>
            <doc-number>102015002298</doc-number>
            <kind>A1</kind>
            <date>20150917</date>
          </document-id>
          <application-date>
            <date>20150223</date>
          </application-date>
        </family-member>
        <family-member>
          <document-id>
            <country>EP</country>
            <doc-number>2921487</doc-number>
            <kind>A1</kind>
            <date>20150923</date>
          </document-id>
          <application-date>
            <date>20150223</date>
          </application-date>
        </family-member>
        <family-member>
          <document-id>
            <country>TW</country>
            <doc-number>201542537</doc-number>
            <kind>A</kind>
            <date>20151116</date>
          </document-id>
          <application-date>
            <date>20150316</date>
          </application-date>
        </family-member>
        <family-member>
          <document-id>
            <country>US</country>
            <doc-number>20150259602</doc-number>
            <kind>A1</kind>
            <date>20150917</date>
          </document-id>
          <application-date>
            <date>20150317</date>
          </application-date>
        </family-member>
        <family-member>
          <document-id>
            <country>CN</country>
            <doc-number>104926765</doc-number>
            <kind>A</kind>
            <date>20150923</date>
          </document-id>
          <application-date>
            <date>20150317</date>
          </application-date>
        </family-member>
      </main-family>
      <complete-family family-id="173666135">
        <family-member>
          <document-id>
            <country>KR</country>
            <doc-number>1020150108325</doc-number>
            <kind>A</kind>
            <date>20150925</date>
          </document-id>
          <application-date>
            <date>20150316</date>
          </application-date>
        </family-member>
        <family-member>
          <document-id>
            <country>JP</country>
            <doc-number>2015174864</doc-number>
            <kind>A</kind>
            <date>20151005</date>
          </document-id>
          <application-date>
            <date>20150316</date>
          </application-date>
        </family-member>
        <family-member>
          <document-id>
            <country>DE</country>
            <doc-number>102015002298</doc-number>
            <kind>A1</kind>
            <date>20150917</date>
          </document-id>
          <application-date>
            <date>20150223</date>
          </application-date>
        </family-member>
        <family-member>
          <document-id>
            <country>EP</country>
            <doc-number>2921487</doc-number>
            <kind>A1</kind>
            <date>20150923</date>
          </document-id>
          <application-date>
            <date>20150223</date>
          </application-date>
        </family-member>
        <family-member>
          <document-id>
            <country>TW</country>
            <doc-number>201542537</doc-number>
            <kind>A</kind>
            <date>20151116</date>
          </document-id>
          <application-date>
            <date>20150316</date>
          </application-date>
        </family-member>
        <family-member>
          <document-id>
            <country>US</country>
            <doc-number>20150259602</doc-number>
            <kind>A1</kind>
            <date>20150917</date>
          </document-id>
          <application-date>
            <date>20150317</date>
          </application-date>
        </family-member>
        <family-member>
          <document-id>
            <country>CN</country>
            <doc-number>104926765</doc-number>
            <kind>A</kind>
            <date>20150923</date>
          </document-id>
          <application-date>
            <date>20150317</date>
          </application-date>
        </family-member>
      </complete-family>
    </patent-family>
  </bibliographic-data>
  <abstract id="abstr_eng" date-changed="20150917" lang="eng" format="original">
    <p id="p-a-00001-en" num="0000">4,6-difluorodibenzofuran derivatives of the formula I</p>
    <p id="p-a-00002-en" num="0000">
      <chemistry id="chema-00001-en" num="00001">
        <img id="imga-00001-en" he="18.54mm" wi="69.93mm" alt="embedded image" img-content="chem" file="US20150259602A1_00001.PNG" img-format="png" original="US20150259602A1-20150917-C00001.TIF" />
      </chemistry>
    </p>
    <p id="p-a-00003-en" num="0000">the preparation thereof, the use thereof as components in liquid-crystalline media and electro-optical display elements which contain the liquid-crystalline media.</p>
  </abstract>
  <legal-data date-changed="20151002">
    <legal-event sequence="1">
      <publication-date>
        <date>20150630</date>
      </publication-date>
      <event-code-1>AS</event-code-1>
      <legal-description>ASSIGNMENT</legal-description>
      <status-identifier>N</status-identifier>
      <docdb-publication-number> US  2015259602A1</docdb-publication-number>
      <docdb-application-id>444514795</docdb-application-id>
      <new-owner>MERCK PATENT GMBH, GERMANY</new-owner>
      <free-text-description>ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:REIFFENRATH, VOLKER;BREMER, MATTHIAS;FORTTE, ROCCO;AND OTHERS;SIGNING DATES FROM 20150521 TO 20150622;REEL/FRAME:035996/0381</free-text-description>
    </legal-event>
  </legal-data>
  <description id="descr_eng" lang="eng" format="original" date-changed="20150917">
    <summary>
      <p id="p-00001-en" num="0001">The present invention relates to 4,6-difluorodibenzofuran derivatives, to a process for the preparation thereof, to liquid-crystalline media comprising these derivatives, and to electro-optical display elements containing these liquid-crystalline media. The compounds have negative dielectric anisotropy.</p>
      <p id="p-00002-en" num="0002">Liquid crystals have found widespread use since the first commercially usable liquid-crystalline compounds were found about 30 years ago. Known areas of application of conventional mixtures are, in particular, displays for watches and pocket calculators, and large display panels as used in railway stations, airports and sports arenas. Further areas of application are displays of portable and desktop computers, navigation systems and video applications. For the last-mentioned applications in particular, high demands are made of the response times and contrast of the images.</p>
      <p id="p-00003-en" num="0003">The spatial arrangement of the molecules in a liquid crystal has the effect that many of its properties are direction-dependent. Of particular importance for use in liquid-crystal displays are the optical, dielectric and elastomechanical anisotropies. Depending on whether the molecules are oriented with their longitudinal axes perpendicular or parallel to the two plates of a capacitor, the latter has a different capacitance; in other words, the dielectric constant â of the liquid-crystalline medium has different values for the two orientations. Substances whose dielectric constant is larger when the longitudinal axes of the molecules are oriented perpendicular to the capacitor plates than when they are oriented parallel are referred to as dielectrically positive. In other words, if the dielectric constant â<sub>â¥</sub> parallel to the longitudinal axes of the molecules is larger than the dielectric constant â<sub>â¥</sub> perpendicular to the longitudinal axes of the molecules, the dielectric anisotropy Îâ=â<sub>â¥</sub>ââ<sub>â¥</sub> is greater than zero. Most liquid crystals used in conventional displays fall into this group.</p>
      <p id="p-00004-en" num="0004">Both the polarisability of the molecule and the permanent dipole moment play a role for the dielectric anisotropy. On application of a voltage to the display, the longitudinal axis of the molecules orients itself in such a way that the larger of the dielectric constants becomes effective. The strength of the interaction with the electric field depends on the difference between the two constants.</p>
      <p id="p-00005-en" num="0005">In the case of the liquid-crystalline molecules used in conventional liquid-crystal displays, the dipole moment oriented along the longitudinal axis of the molecules is greater than the dipole moment oriented perpendicular to the longitudinal axis of the molecules.</p>
      <p id="p-00006-en" num="0006">By means of liquid crystals in which the greater dipole moment is oriented parallel to the longitudinal axis of the molecule, very high-performance displays have already been developed. In most cases here, mixtures of from 5 to 20 components are used in order to achieve a sufficiently broad temperature range of the mesophase and short response times and low threshold voltages. However, difficulties are still caused by the strong viewing angle dependence in liquid-crystal displays as are used, for example, for laptops. The best imaging quality can be achieved if the surface of the display is perpendicular to the viewing direction of the observer. If the display is tilted relative to the observation direction, the imaging quality deteriorates drastically under certain circumstances. For greater comfort, attempts are being made to maximise the angle through which the display can be tilted from the viewing direction of an observer without significantly reducing the imaging quality. Attempts have recently been made to improve the viewing-angle dependence using liquid-crystalline compounds whose dipole moment perpendicular to the longitudinal axis of the molecule is larger than that parallel to the longitudinal axis of the molecule. The dielectric anisotropy Îâ is negative in this case. In the field-free state, these molecules are oriented with their longitudinal axis perpendicular to the glass surface of the display. Application of an electric field causes them to orient themselves more or less parallel to the glass surfaces. In this way, it has been possible to achieve an improvement in the viewing-angle dependence. Displays of this type are known as VA-TFT (âvertically alignedâ) displays.</p>
      <p id="p-00007-en" num="0007">Development in the area of liquid-crystalline materials is still far from complete. In order to improve the properties of liquid-crystalline display elements, attempts are constantly being made to develop novel compounds which enable optimisation of such displays.</p>
      <p id="p-00008-en" num="0008">The specifications WO 02/055463, DE 102005012585 and EP 1752510 disclose dibenzofuran derivatives for use as liquid-crystalline material. The compounds differ from the compounds according to the invention in the substitution of the dibenzofuran structure. The specifications do not disclose any physical data on comparable compounds.</p>
      <p id="p-00009-en" num="0009">It is an object of the present invention to provide compounds having advantageous properties for use in liquid-crystalline media. In particular, they should have negative dielectric anisotropy, which makes them particularly suitable for use in liquid-crystalline media for VA displays. Irrespective of the dielectric anisotropy corresponding to the display type, compounds are desired which have a favourable combination of the applicational parameters. Of these parameters, which are to be optimised simultaneously, particular mention should be made of a high clearing point, a low rotational viscosity, an optical anisotropy in the use range, and the properties which serve to achieve mixtures having the desired liquid-crystalline phases over a broad temperature range (lower melting point, good miscibility with other liquid-crystalline components of the desired type).</p>
      <p id="p-00010-en" num="0010">This object is achieved in accordance with the invention by compounds of the general formula I</p>
      <p id="p-00011-en" num="0000">
        <chemistry id="chem-00001-en" num="00002">
          <img id="img-00001-en" he="18.54mm" wi="69.93mm" alt="embedded image" img-content="chem" file="US20150259602A1_00002.PNG" img-format="png" original="US20150259602A1-20150917-C00002.TIF" />
        </chemistry>
        <ul id="ul-00001-en" list-style="none">
          <li>in which</li>
          <li>m and n are each, independently of one another, 0 or 1, preferably 1,</li>
          <li>R<sup>1 </sup>and R<sup>2</sup>, independently of one another, denote an unsubstituted alkyl radical having 1 to 15 carbon atoms or an alkenyl or alkynyl radical having 2 to 15 C atoms, each of which are optionally mono- or polyhalogenated.</li>
        </ul>
      </p>
      <p id="p-00012-en" num="0014">The compounds have a clearly negative Îâ and are therefore suitable, in particular, for use in VA-TFT displays. The compounds according to the invention preferably have a Îââ¦â4 and particularly preferably a Îââ¦â8. They exhibit good miscibility with the conventional substances used in liquid-crystal mixtures for displays, i.e. they have good solubility therein. The rotational viscosities of the compounds and of the resultant liquid-crystalline mixtures are advantageously low.</p>
      <p id="p-00013-en" num="0015">The other physical, physicochemical or electro-optical parameters of the compounds according to the invention are also advantageous for use of the compounds in liquid-crystalline media. The liquid-crystalline media which comprise these compounds have, in particular, an adequate width of the nematic phase and good low-temperature and long-term stability as well as sufficiently high clearing points. The low melting points give an indication of the advantageous mixing behaviour. Furthermore, the compounds of the formula I according to the invention have values of the optical anisotropy În which are suitable, in particular, for use in VA-TFT displays. The compounds according to the invention preferably have a În of greater than 0.15 and less than 0.25.</p>
      <p id="p-00014-en" num="0016">The parameters m and n preferably have a value of 1 or 2, particularly 2, in the sum m+n. n is thus preferably 1, and m is preferably 0 or 1, particularly preferably 1.</p>
      <p id="p-00015-en" num="0017">R<sup>1 </sup>and R<sup>2 </sup>preferably each, independently of one another, denote an alkyl radical or alkenyl radical having 1 to 7 or 2 to 7 carbon atoms respectively. R<sup>1 </sup>and R<sup>2 </sup>in the general formula I are particularly preferably, independently of one another, an alkyl radical having 2 to 5 C atoms. The radicals R<sup>1 </sup>and R<sup>2 </sup>are preferably different here.</p>
      <p id="p-00016-en" num="0018">In the case where m=1, Râ² preferably denotes an alkyl or alkenyl group, particularly preferably an alkyl group having 1-7 C atoms, particularly preferably having 2 to 5 C atoms. In the case where n=1, R<sup>2 </sup>preferably denotes an alkyl or alkenyl group, particularly preferably an alkyl group having 1-7 C atoms, particularly preferably having 2 to 5 C atoms. The sum of the number of carbon atoms in R<sup>1 </sup>and R<sup>2 </sup>together is preferably 4, 5, 6, 7, 8, 9 or 10, particularly preferably 5, 6, 7, 8 or 9.</p>
      <p id="p-00017-en" num="0019">In the case where m=0, Râ² preferably denotes an alkyl or alkenyl group, particularly preferably an alkyl group having 1-7 C atoms, particularly preferably having 2 to 5 C atoms. In the case where n=0, R<sup>2 </sup>preferably denotes an alkyl or alkenyl group, particularly preferably an alkyl group having 1-7 C atoms, particularly preferably having 2 to 5 C atoms.</p>
      <p id="p-00018-en" num="0020">If R<sup>1 </sup>and R<sup>2 </sup>in the formula I each, independently of one another, represent an alkyl radical, these are straight-chain or branched. Each of these radicals is preferably straight-chain, has 1, 2, 3, 4, 5, 6 or 7 C atoms and is accordingly preferably methyl, ethyl, propyl, butyl, pentyl, hexyl or heptyl.</p>
      <p id="p-00019-en" num="0021">R<sup>1 </sup>and R<sup>2 </sup>in the formula I may furthermore each, independently of one another, be an alkenyl radical having 2 to 15 C atoms which is straight-chain or branched and has at least one CâC double bond. It is preferably straight-chain and has 2 to 7 C atoms. Accordingly, it is preferably vinyl, prop-1- or -2-enyl, but-1-, -2- or -3-enyl, pent-1-, -2-, -3- or -4-enyl, hex-1-, -2-, -3-, -4- or -5-enyl, or hept-1-, -2-, -3-, -4-, -5- or -6-enyl. If the two C atoms of the CâC double bond are substituted, the alkenyl radical can be in the form of the E and/or Z isomer (trans/cis). In general, the respective E isomers are preferred. Of the alkenyl radicals, particular preference is given to prop-2-enyl, but-2- or -3-enyl, and pent-3- or -4-enyl.</p>
      <p id="p-00020-en" num="0022">R<sup>1 </sup>and R<sup>2 </sup>in the formula I may, independently of one another, also be an alkynyl radical having 2 to 15 C atoms which is straight-chain or branched and has at least one CâC triple bond. Preference is given to 1- or 2-propynyl and 1-, 2- or 3-propynyl.</p>
      <p id="p-00021-en" num="0023">Halogen in connection with the present invention denotes fluorine, chlorine, bromine or iodine, in particular fluorine or chlorine.</p>
      <p id="p-00022-en" num="0024">In connection with the present invention, the term âalkylââunless defined otherwise elsewhere in this description or in the claimsâdenotes a straight-chain or branched, saturated, aliphatic hydrocarbon radical having 1 to 15 (i.e. 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 or 15) carbon atoms.</p>
      <p id="p-00023-en" num="0025">Particular preference is given to compounds of the formula I according to the invention selected from the sub-formulae IA to IC:</p>
      <p id="p-00024-en" num="0000">
        <chemistry id="chem-00002-en" num="00003">
          <img id="img-00002-en" he="77.30mm" wi="69.93mm" alt="embedded image" img-content="chem" file="US20150259602A1_00003.PNG" img-format="png" original="US20150259602A1-20150917-C00003.TIF" />
        </chemistry>
      </p>
      <p id="p-00025-en" num="0000">in which alkyl denotes an alkyl radical having 1 to 15 carbon atoms, and R<sup>2 </sup>has the meanings as defined for the formula I. The alkyl radical is preferably unbranched (n-alkyl). It preferably has 1 to 7 carbon atoms.</p>
      <p id="p-00026-en" num="0026">Particularly preferred compounds of the formula I for which n+m=2 are those of the formulae:</p>
      <p id="p-00027-en" num="0000">
        <chemistry id="chem-00003-en" num="00004">
          <img id="img-00003-en" he="152.74mm" wi="75.35mm" alt="embedded image" img-content="chem" file="US20150259602A1_00004.PNG" img-format="png" original="US20150259602A1-20150917-C00004.TIF" />
        </chemistry>
      </p>
      <p id="p-00028-en" num="0000">of these particularly preferably the compounds of the formulae IA1 to IA3.</p>
      <p id="p-00029-en" num="0027">Very particularly preferred compounds of the formula I for which n+m=1 are the following:</p>
      <p id="p-00030-en" num="0000">
        <chemistry id="chem-00004-en" num="00005">
          <img id="img-00004-en" he="211.41mm" wi="74.08mm" alt="embedded image" img-content="chem" file="US20150259602A1_00005.PNG" img-format="png" original="US20150259602A1-20150917-C00005.TIF" />
        </chemistry>
      </p>
      <p id="p-00031-en" num="0028">If radicals or substituents of the compounds according to the invention or the compounds according to the invention themselves are in the form of optically active or stereoisomeric radicals, substituents or compounds since they have, for example, a centre of asymmetry, these are likewise encompassed by the present invention. It goes without saying here that the compounds of the general formula I according to the invention may exist in isomerically pure form, for example as pure enantiomers, diastereomers, E or Z isomers, trans or cis isomers, or as a mixture of a plurality of isomers in any desired ratio, for example as a racemate, E/Z isomer mixture or as a cis/trans isomer mixture.</p>
      <p id="p-00032-en" num="0029">The 1,4-substituted cyclohexyl ring of the formula</p>
      <p id="p-00033-en" num="0000">
        <chemistry id="chem-00005-en" num="00006">
          <img id="img-00005-en" he="9.99mm" wi="43.10mm" alt="embedded image" img-content="chem" file="US20150259602A1_00006.PNG" img-format="png" original="US20150259602A1-20150917-C00006.TIF" />
        </chemistry>
      </p>
      <p id="p-00034-en" num="0000">in the compounds disclosed for liquid-crystalline media preferably has the trans configuration, i.e. the two substituents are both in the equatorial position in the thermodynamically preferred chair conformation.</p>
      <p id="p-00035-en" num="0030">The compounds of the general formula I can be prepared by methods known per se, as described in the literature (for example in the standard works, such as Houben-Weyl, Methoden der organischen Chemie [Methods of Organic Chemistry], Georg-Thieme-Verlag, Stuttgart), to be precise under reaction conditions which are known and suitable for the said reactions. Use can be made here of variants known per se which are not mentioned here in greater detail.</p>
      <p id="p-00036-en" num="0031">If desired, the starting materials can also be formed in situ by not isolating them from the reaction mixture, but instead immediately converting them further into the compounds of the general formula I.</p>
      <p id="p-00037-en" num="0032">The syntheses of compounds of the general formula I according to the invention are described by way of example in the examples. The starting substances can be obtained by generally accessible literature procedures or are commercially available.</p>
      <p id="p-00038-en" num="0033">Particularly suitable synthetic routes to the compounds according to the invention are explained below with reference to Schemes 1, 2, 3 and 4. The substituents R<sup>1</sup>, R<sup>2 </sup>and the indices m and n in the following schemes have the meanings as for the formula I.</p>
      <p id="p-00039-en" num="0034">The synthesis of the compounds of the formula I containing two alkoxy groups (R<sup>1</sup>, R<sup>2</sup>) is carried out starting from the basic compound dibenzofuran (cf. Scheme 1).</p>
      <p id="p-00040-en" num="0000">
        <chemistry id="chem-00006-en" num="00007">
          <img id="img-00006-en" he="243.59mm" wi="67.39mm" alt="embedded image" img-content="chem" file="US20150259602A1_00007.PNG" img-format="png" original="US20150259602A1-20150917-C00007.TIF" />
        </chemistry>
        <chemistry id="chem-00007-en" num="00008">
          <img id="img-00007-en" he="145.46mm" wi="54.86mm" alt="embedded image" img-content="chem" file="US20150259602A1_00008.PNG" img-format="png" original="US20150259602A1-20150917-C00008.TIF" />
        </chemistry>
      </p>
      <p id="p-00041-en" num="0035">The compounds containing only one alkoxy group (m+n=1) are prepared in a modification of the above synthesis in accordance with Scheme 2.</p>
      <p id="p-00042-en" num="0000">
        <chemistry id="chem-00008-en" num="00009">
          <img id="img-00008-en" he="99.40mm" wi="71.88mm" alt="embedded image" img-content="chem" file="US20150259602A1_00009.PNG" img-format="png" original="US20150259602A1-20150917-C00009.TIF" />
        </chemistry>
      </p>
      <p id="p-00043-en" num="0036">The synthesis of the compounds of the formula I containing two alkyl groups (m+n=0) is carried out in a further modification of the above syntheses (Scheme 3).</p>
      <p id="p-00044-en" num="0000">
        <chemistry id="chem-00009-en" num="00010">
          <img id="img-00009-en" he="106.68mm" wi="71.88mm" alt="embedded image" img-content="chem" file="US20150259602A1_00010.PNG" img-format="png" original="US20150259602A1-20150917-C00010.TIF" />
        </chemistry>
      </p>
      <p id="p-00045-en" num="0037">Starting from the intermediate (A), the OH group is esterified using trifluoromethanesulfonic acid and subsequently subjected to a Pd-catalysed coupling reaction with an organic zinc-halogen compound. The other steps for the generation of the second alkyl group correspond to those from Scheme 2.</p>
      <p id="p-00046-en" num="0038">An alternative synthesis of the compounds of the formula I arises from the following Scheme 4.</p>
      <p id="p-00047-en" num="0000">
        <chemistry id="chem-00010-en" num="00011">
          <img id="img-00010-en" he="181.86mm" wi="68.50mm" alt="embedded image" img-content="chem" file="US20150259602A1_00011.PNG" img-format="png" original="US20150259602A1-20150917-C00011.TIF" />
        </chemistry>
      </p>
      <p id="p-00048-en" num="0039">If the final reaction arrow in Scheme 4 is replaced by the final reaction arrow in Scheme 3, compounds according to the invention in which m+n=1, i.e. containing an alkoxy group, then arise.</p>
      <p id="p-00049-en" num="0040">Reaction Schemes 1 to 4 depicted should only be regarded as illustrative. The person skilled in the art will be able to carry out corresponding variations of the syntheses presented, and also follow other suitable synthetic routes in order to obtain compounds of the formula I.</p>
      <p id="p-00050-en" num="0041">According to the syntheses depicted above, the present invention also encompasses, in an embodiment, one or more processes for the preparation of compounds of the formula I.</p>
      <p id="p-00051-en" num="0042">The invention thus encompasses a process for the preparation of compounds of the formula I which is characterised in that it includes a process step in which a compound of the formula (B)</p>
      <p id="p-00052-en" num="0000">
        <chemistry id="chem-00011-en" num="00012">
          <img id="img-00011-en" he="20.07mm" wi="69.93mm" alt="embedded image" img-content="chem" file="US20150259602A1_00012.PNG" img-format="png" original="US20150259602A1-20150917-C00012.TIF" />
        </chemistry>
        <ul id="ul-00002-en" list-style="none">
          <li>
            <ul id="ul-00003-en" list-style="none">
              <li>in which m, R<sup>1 </sup>independently are defined as in formula I, <br /> is deprotonated at position 3 by means of a deprotonation reagent and converted into a compound of the formula (C) </li>
            </ul>
          </li>
        </ul>
      </p>
      <p id="p-00053-en" num="0000">
        <chemistry id="chem-00012-en" num="00013">
          <img id="img-00012-en" he="20.07mm" wi="69.93mm" alt="embedded image" img-content="chem" file="US20150259602A1_00013.PNG" img-format="png" original="US20150259602A1-20150917-C00013.TIF" />
        </chemistry>
        <ul id="ul-00004-en" list-style="none">
          <li>
            <ul id="ul-00005-en" list-style="none">
              <li>in which, independently,</li>
              <li>m, R<sup>1 </sup>are defined as in formula I,</li>
              <li>X denotes B(OR)<sub>2</sub>, âC(OH)R or OH, and</li>
              <li>R denotes an alkyl radical having 1 to 14 C atoms, <br /> and is converted into a compound of the formula I in one or more further process steps. </li>
            </ul>
          </li>
        </ul>
      </p>
      <p id="p-00054-en" num="0048">The various groups X in formula (C) are obtained by reacting the aromatic compound metallated in the ortho-position to the fluorine atom with trialkyl borate B(OR)<sub>3 </sub>to give X=âB(OR)<sub>2</sub>, with aldehyde RCHO to give âC(OH)R, and optionally converting the boronic acid group X=âB(OR)<sub>2 </sub>formed into OH under oxidative conditions (for example using H<sub>2</sub>O<sub>2</sub>). Preferred conditions for the metallation are reaction with an alkyllithium compound, such as n-BuLi, in THF, at about â70Â° C., then addition of the electrophile.</p>
      <p id="p-00055-en" num="0049">The process and the subsequent work-up of the reaction mixture can basically be carried out as a batch reaction or in a continuous reaction procedure. The continuous reaction procedure encompasses, for example, reaction in a continuous stirred-tank reactor, a stirred-reactor cascade, a loop or cross-flow reactor, a flow tube or in a microreactor. The reaction mixtures are optionally worked up, as necessary, by filtration via solid phases, chromatography, separation between immiscible phases (for example extraction), adsorption onto solid supports, removal of solvents and/or azeotropic mixtures by distillation, selective distillation, sublimation, crystallisation, co-crystallisation or by nanofiltration on membranes.</p>
      <p id="p-00056-en" num="0050">As already mentioned, the compounds of the general formula I can be used in liquid-crystalline media. The present invention therefore also relates to a liquid-crystalline medium comprising at least two liquid-crystalline compounds, comprising at least one compound of the general formula I.</p>
      <p id="p-00057-en" num="0051">The present invention also relates to liquid-crystalline media comprising 2 to 40, preferably 4 to 30, components as further constituents besides one or more compounds of the formula I according to the invention. These media particularly preferably comprise 7 to 25 components besides one or more compounds according to the invention. These further constituents are preferably selected from nematic or nematogenic (monotropic or isotropic) substances, in particular substances from the classes of the azoxybenzenes, benzylideneanilines, biphenyls, terphenyls, 1,3-dioxanes, 2,5-tetrahydropyrans, phenyl or cyclohexyl benzoates, phenyl or cyclohexyl esters of cyclohexanecarboxylic acid, phenyl or cyclohexyl esters of cyclohexyl-benzoic acid, phenyl or cyclohexyl esters of cyclohexylcyclohexanecarboxylic acid, cyclohexylphenyl esters of benzoic acid, of cyclohexanecarboxylic acid or of cyclohexylcyclohexanecarboxylic acid, phenylcyclohexanes, cyclohexylbiphenyls, phenylcyclohexylcyclohexanes, cyclohexylcyclohexanes, cyclohexylcyclohexylcyclohexenes, 1,4-biscyclohexylbenzenes, 4â²,4â²-biscyclohexylbiphenyls, phenyl- or cyclohexylpyrimidines, phenyl- or cyclohexylpyridines, phenyl- or cyclohexyldioxanes, phenyl- or cyclohexyl-1,3-dithianes, 1,2-diphenylethanes, 1,2-dicyclohexylethanes, 1-phenyl-2-cyclohexylethanes, 1-cyclohexyl-2-(4-phenylcyclohexyl)ethanes, 1-cyclohexyl-2-biphenylethanes, 1-phenyl-2-cyclohexylphenylethanes, optionally halogenated stilbenes, benzyl phenyl ethers, tolans and substituted cinnamic acids. The 1,4-phenylene groups in these compounds may also be mono- or polyfluorinated.</p>
      <p id="p-00058-en" num="0052">The most important compounds suitable as further constituents of media according to the invention can be characterised by the formulae (II), (III), (IV), (V) and (VI):</p>
      <p id="p-00059-en" num="0000">[in-line-formulae]Râ²-L-E-Râ³ââ(II)[/in-line-formulae]</p>
      <p id="p-00060-en" num="0000">[in-line-formulae]Râ²-L-COO-E-Râ³ââ(III)[/in-line-formulae]</p>
      <p id="p-00061-en" num="0000">[in-line-formulae]Râ²-L-OOC-E-Râ³ââ(IV)[/in-line-formulae]</p>
      <p id="p-00062-en" num="0000">[in-line-formulae]Râ²-L-CH<sub>2</sub>CH<sub>2</sub>-E-Râ³ââ(V)[/in-line-formulae]</p>
      <p id="p-00063-en" num="0000">[in-line-formulae]Râ²-L-CF<sub>2</sub>O-E-Râ³ââ(VI)[/in-line-formulae]</p>
      <p id="p-00064-en" num="0053">In the formulae (II), (III), (IV), (V) and (VI), L and E, which may be identical or different, each, independently of one another, denote a divalent radical from the group formed by -Phe-, -Cyc-, -Phe-Phe-, -Phe-Cyc-, -Cyc-Cyc-, -Pyr-, -Dio-, -Thp-, -G-Phe- and -G-Cyc- and their mirror images, where Phe denotes unsubstituted or fluorine-substituted 1,4-phenylene, Cyc denotes trans-1,4-cyclohexylene or 1,4-cyclohexenylene, Pyr denotes pyrimidine-2,5-diyl or pyridine-2,5-diyl, Dio denotes 1,3-dioxane-2,5-diyl, Thp denotes tetrahydropyran-2,5-diyl and G denotes 2-(trans-1,4-cyclohexyl)ethyl, pyrimidine-2,5-diyl, pyridine-2,5-diyl, 1,3-dioxane-2,5-diyl or tetrahydropyran-2,5-diyl.</p>
      <p id="p-00065-en" num="0054">One of the radicals L and E is preferably Cyc or Phe. E is preferably Cyc, Phe or Phe-Cyc. The media according to the invention preferably comprise one or more components selected from the compounds of the formulae (II), (III), (IV), (V) and (VI) in which L and E are selected from the group consisting of Cyc and Phe and simultaneously one or more components selected from the compounds of the formulae (II), (III), (IV), (V) and (VI) in which one of the radicals L and E is selected from the group consisting of Cyc and Phe and the other radical is selected from the group consisting of -Phe-Phe-, -Phe-Cyc-, -Cyc-Cyc-, -G-Phe- and -G-Cyc-, and optionally one or more components selected from the compounds of the formulae (II), (III), (IV), (V) and (VI) in which the radicals L and E are selected from the group consisting of -Phe-Cyc-, -Cyc-Cyc-, -G-Phe- and -G-Cyc-.</p>
      <p id="p-00066-en" num="0055">In a smaller sub-group of the compounds of the formulae (II), (III), (IV), (V) and (VI), Râ² and Râ³ each, independently of one another, denote alkyl, alkenyl, alkoxy, alkoxyalkyl (oxaalkyl), alkenyloxy or alkanoyloxy having up to 8 C atoms. This smaller sub-group is called group A below, and the compounds are referred to by the sub-formulae (IIa), (IIIa), (IVa), (Va) and (VIa). In most of these compounds, Râ² and Râ³ are different from one another, one of these radicals usually being alkyl, alkenyl, alkoxy or alkoxyalkyl (oxaalkyl).</p>
      <p id="p-00067-en" num="0056">In another smaller sub-group of the compounds of the formulae (II), (III), (IV), (V) and (VI), which is known as group B, E denotes</p>
      <p id="p-00068-en" num="0000">
        <chemistry id="chem-00013-en" num="00014">
          <img id="img-00013-en" he="15.66mm" wi="23.79mm" alt="embedded image" img-content="chem" file="US20150259602A1_00014.PNG" img-format="png" original="US20150259602A1-20150917-C00014.TIF" />
        </chemistry>
      </p>
      <p id="p-00069-en" num="0057">In the compounds of group B, which are referred to by the sub-formulae (IIb), (IIIb), (IVb), (Vb) and (VIb), Râ² and Râ³ are as defined for the compounds of the sub-formulae (IIa) to (VIa) and are preferably alkyl, alkenyl, alkoxy or alkoxyalkyl (oxaalkyl).</p>
      <p id="p-00070-en" num="0058">In a further smaller sub-group of the compounds of the formulae (II), (III), (IV), (V) and (VI), Râ³ denotesâCN. This sub-group is referred to below as group C, and the compounds of this sub-group are correspondingly described by sub-formulae (IIc), (IIIc), (IVc), (Vc) and (VIc). In the compounds of the sub-formulae (IIc), (IIIc), (IVc), (Vc) and (VIc), Râ² is as defined for the compounds of the sub-formulae (IIa) to (VIa) and is preferably alkyl, alkenyl, alkoxy or alkoxyalkyl (oxaalkyl).</p>
      <p id="p-00071-en" num="0059">Besides the preferred compounds of groups A, B and C, other compounds of the formulae (II), (III), (IV), (V) and (VI) having other variants of the proposed substituents are also customary. All these substances are obtainable by methods which are known from the literature or analogously thereto.</p>
      <p id="p-00072-en" num="0060">Besides the compounds of the general formula I according to the invention, the media according to the invention preferably comprise one or more compounds from groups A, B and/or C. The proportions by weight of the compounds from these groups in the media according to the invention are:</p>
      <p id="p-00073-en" num="0000">group A: <br /> from 0 to 90%, preferably from 20 to 90%, in particular from 30 to 90%. <br /> group B: <br /> from 0 to 80%, preferably from 10 to 80%, in particular from 10 to 70%. <br /> group C: <br /> from 0 to 80%, preferably from 5 to 80%, in particular from 5 to 50%. </p>
      <p id="p-00074-en" num="0061">The media according to the invention preferably comprise from 1 to 40%, particularly preferably from 5 to 30%, of the compounds of the formula I according to the invention. The media preferably comprise one, two, three, four or five compounds of the formula I according to the invention.</p>
      <p id="p-00075-en" num="0062">The media according to the invention are prepared in a manner conventional per se. In general, the components are dissolved in one another, preferably at elevated temperature. By means of suitable additives, the liquid-crystalline phases of the present invention can be modified in such a way that they can be used in all types of liquid-crystal display element that have been disclosed hitherto. Additives of this type are known to the person skilled in the art and are described in detail in the literature (H. Kelker/R. Hatz, Handbook of Liquid Crystals, Verlag Chemie, Weinheim, 1980). For example, pleochroic dyes can be added for the production of coloured guest-host systems or substances can be added in order to modify the dielectric anisotropy, the viscosity and/or the alignment of the nematic phases.</p>
      <p id="p-00076-en" num="0063">Owing to their negative Îâ, the compounds of the formula I are particularly suitable for use in VA-TFT displays.</p>
      <p id="p-00077-en" num="0064">The present invention therefore also relates to electro-optical liquid-crystal display elements containing a liquid-crystalline medium according to the invention.</p>
      <p id="p-00078-en" num="0065">Further combinations of the embodiments and variants of the invention in accordance with the description arise from the claims.</p>
      <p id="p-00079-en" num="0066">The invention is explained in greater detail below with reference to working examples, but without intending to be restricted thereby. The person skilled in the art will be able to glean from the examples working details that are not given in detail in the general description, generalise them in accordance with general expert knowledge and apply them to a specific problem.</p>
      <p id="p-00080-en" num="0067">Besides the usual and well-known abbreviations, the following abbreviations are used:</p>
      <p id="p-00081-en" num="0000">C: crystalline phase; N: nematic phase; Sm: smectic phase; I: isotropic phase. The numbers between these symbols show the transition temperatures of the substance concerned. <br /> Temperature data are in Â° C., unless indicated otherwise. </p>
      <p id="p-00082-en" num="0068">Physical, physicochemical or electro-optical parameters are determined by generally known methods, as described, inter alia, in the brochure âMerck Liquid CrystalsâLicristalÂ®âPhysical Properties of Liquid CrystalsâDescription of the Measurement Methodsâ, 1998, Merck KGaA, Darmstadt.</p>
      <p id="p-00083-en" num="0069">Above and below, În denotes the optical anisotropy (589 nm, 20Â° C.) and Îâ denotes the dielectric anisotropy (1 kHz, 20Â° C.). The dielectric anisotropy Îâ is determined at 20Â° C. and 1 kHz. The optical anisotropy În is determined at 20Â° C. and a wavelength of 589.3 nm.</p>
      <p id="p-00084-en" num="0070">The Îâ and În values and the rotational viscosity (Î³<sub>1</sub>) of the compounds according to the invention are obtained by linear extrapolation from liquid-crystalline mixtures consisting of 5 to 10% of the respective compound according to the invention and 90-95% of the commercially available liquid-crystal mixture ZLI-2857 (for Îâ) or ZLI-4792 (for În, Î³<sub>1</sub>) (mixtures, Merck KGaA, Darmstadt).</p>
      <p id="p-00085-en" num="0071">Above and below, the abbreviations have the following meanings:</p>
      <p id="p-00086-en" num="0000">MTBE methyl tert-butyl ether <br /> THF tetrahydrofuran <br /> DMF dimethylformamide <br /> DMAP 4-(dimethylamino)pyridine </p>
      <heading id="h-00001-en" level="2">NSFI N-fluorobenzenesulfonimide</heading>
      <p id="p-00087-en" num="0072">sat. soln. saturated solution <br /> n-BuLi n-butyllithium, solution in hexane <br /> RT room temperature, about 20Â° C. <br /> TIPSCI triisopropylsilyl chloride </p>
      <p id="p-00088-en" num="0073">Without further elaboration, it is believed that one skilled in the art can, using the preceding description, utilize the present invention to its fullest extent. The preceding preferred specific embodiments are, therefore, to be construed as merely illustrative, and not limitative of the remainder of the disclosure in any way whatsoever.</p>
      <p id="p-00089-en" num="0074">In the foregoing and in the examples, all temperatures are set forth uncorrected in degrees Celsius and, all parts and percentages are by weight, unless otherwise indicated.</p>
      <p id="p-00090-en" num="0075">The entire disclosures of all applications, patents and publications, cited herein and of corresponding DE application No. 10 2014 003 600.6, filed Mar. 17, 2014, are incorporated by reference herein.</p>
    </summary>
    <detailed-desc>
      <heading id="h-00002-en" level="1">EXAMPLES</heading>
      <p id="p-00091-en" num="0076">The starting substances can be obtained in accordance with generally accessible literature procedures or commercially.</p>
      <heading id="h-00003-en" level="1">Example 1</heading>
      <heading id="h-00004-en" level="1">3-Butoxy-4,6-difluoro-7-propoxydibenzofuran</heading>
      <p id="p-00092-en" num="0077">
        <chemistry id="chem-00014-en" num="00015">
          <img id="img-00014-en" he="17.02mm" wi="53.51mm" alt="embedded image" img-content="chem" file="US20150259602A1_00015.PNG" img-format="png" original="US20150259602A1-20150917-C00015.TIF" />
        </chemistry>
      </p>
      <heading id="h-00005-en" level="2">Step 1</heading>
      <p id="p-00093-en" num="0078">
        <chemistry id="chem-00015-en" num="00016">
          <img id="img-00015-en" he="35.81mm" wi="75.86mm" alt="embedded image" img-content="chem" file="US20150259602A1_00016.PNG" img-format="png" original="US20150259602A1-20150917-C00016.TIF" />
        </chemistry>
      </p>
      <p id="p-00094-en" num="0079">50 g of dibenzofuran are initially introduced in 1500 ml of THF, and 152 g of 15% BuLi soln. in hexane are added dropwise at â60 to â75Â° C. The mixture is warmed to RT and stirred for a further 3 h. The mixture is then re-cooled to â75Â° C., and a solution of 112.5 g of N-fluorobenzenesulfonimide in 1000 ml of THF is added at â75 to â60Â° C. After a further 30 min at â70Â° C., the reaction mixture is allowed to warm to ambient temperature, and the batch is hydrolysed using water and subjected to extractive work-up. The crude product (red-brown oil) is purified by chromatography (eluent: n-heptane).</p>
      <p id="p-00095-en" num="0080">White crystals.</p>
      <heading id="h-00006-en" level="2">Step 2</heading>
      <p id="p-00096-en" num="0081">
        <chemistry id="chem-00016-en" num="00017">
          <img id="img-00016-en" he="37.51mm" wi="75.86mm" alt="embedded image" img-content="chem" file="US20150259602A1_00017.PNG" img-format="png" original="US20150259602A1-20150917-C00017.TIF" />
        </chemistry>
      </p>
      <p id="p-00097-en" num="0082">40 g of 4-fluorodibenzofuran are initially introduced in 450 ml of THF, and 96 g of 15% BuLi soln. in hexane are added dropwise at â60 to â75Â° C. The mixture is stirred for a further 2 hours. A solution of 25 g of trimethyl borate in 80 ml of THF is then added at â75 to â60Â° C. After a further 30 min at â70Â° C., the reaction mixture is allowed to warm to ambient temperature, and the batch is slowly hydrolysed using a mixture of 30 g of glacial acetic acid and 40 ml of water. 40 g of 30% hydrogen peroxide are subsequently added dropwise at such a rate that the temperature does not exceed 45Â° C. The mixture is stirred at RT for a further 12 h and subjected to extractive work-up.</p>
      <p id="p-00098-en" num="0083">The crude product is purified by chromatography (eluent: n-heptane/MTB 4/1).</p>
      <p id="p-00099-en" num="0084">White crystals.</p>
      <heading id="h-00007-en" level="2">Step 3</heading>
      <p id="p-00100-en" num="0085">
        <chemistry id="chem-00017-en" num="00018">
          <img id="img-00017-en" he="36.91mm" wi="75.86mm" alt="embedded image" img-content="chem" file="US20150259602A1_00018.PNG" img-format="png" original="US20150259602A1-20150917-C00018.TIF" />
        </chemistry>
      </p>
      <p id="p-00101-en" num="0086">36.8 g of 4-fluorodibenzofuran-3-ol, 13.6 g of imidazole and 24.5 g of DMAP are dissolved in 700 ml of DMF, and a solution of 55 g of chloro-triisopropylsilane in 35 ml of DMF is added at 25Â° C. The mixture is stirred at RT for a further 12 h, and the batch is carefully poured into ice-water and subjected to extractive work-up.</p>
      <p id="p-00102-en" num="0087">The crude product is purified by chromatography (eluent: n-heptane/chlorobutane 9/1).</p>
      <p id="p-00103-en" num="0088">Colourless oil.</p>
      <heading id="h-00008-en" level="2">Step 4</heading>
      <p id="p-00104-en" num="0089">
        <chemistry id="chem-00018-en" num="00019">
          <img id="img-00018-en" he="41.23mm" wi="75.86mm" alt="embedded image" img-content="chem" file="US20150259602A1_00019.PNG" img-format="png" original="US20150259602A1-20150917-C00019.TIF" />
        </chemistry>
      </p>
      <p id="p-00105-en" num="0090">30.8 g of (4-fluorodibenzofuran-3-yloxy)triisopropylsilane are initially introduced in 850 ml of THF, and 106 g (3 eq.) of 15% BuLi soln. in hexane are added dropwise at â60 to â75Â° C. The mixture is warmed to â40Â° C. and stirred at this temperature for a further 5 h. The mixture is then re-cooled to â65Â° C., and a solution of 78.8 g of N-fluorobenzenesulfonimide in 300 ml of THF is added at â65 to â50Â° C. After a further 30 min at â50Â° C., the reaction mixture is allowed to warm to ambient temperature, and the batch is hydrolysed using water and subjected to extractive work-up.</p>
      <p id="p-00106-en" num="0091">The crude product (red-brown oil) is purified by chromatography (eluent: n-heptane/chlorobutane 4/1) and recrystallised from ethanol.</p>
      <p id="p-00107-en" num="0092">White crystals.</p>
      <heading id="h-00009-en" level="2">Step 5</heading>
      <p id="p-00108-en" num="0093">
        <chemistry id="chem-00019-en" num="00020">
          <img id="img-00019-en" he="40.05mm" wi="75.86mm" alt="embedded image" img-content="chem" file="US20150259602A1_00020.PNG" img-format="png" original="US20150259602A1-20150917-C00020.TIF" />
        </chemistry>
      </p>
      <p id="p-00109-en" num="0094">15.4 g of (4,6-difluorodibenzofuran-3-yloxy)triisopropylsilane are dissolved in 150 ml of THF, and 57 ml of a 1 M solution of tetrabutylammonium fluoride in THF are added at 5Â° C. The mixture is stirred at RT for a further 30 min and subjected to extractive work-up.</p>
      <p id="p-00110-en" num="0095">The crude product is purified by chromatography (eluent: n-heptane/MTB 2/1) and recrystallised from heptane/toluene 1/1.5.</p>
      <p id="p-00111-en" num="0096">White crystals.</p>
      <heading id="h-00010-en" level="2">Step 6</heading>
      <p id="p-00112-en" num="0097">
        <chemistry id="chem-00020-en" num="00021">
          <img id="img-00020-en" he="40.72mm" wi="75.86mm" alt="embedded image" img-content="chem" file="US20150259602A1_00021.PNG" img-format="png" original="US20150259602A1-20150917-C00021.TIF" />
        </chemistry>
      </p>
      <p id="p-00113-en" num="0098">17.3 g of 4,6-difluorodibenzofuran-3-ol are boiled under reflux with 14.5 g of n-propyl bromide and 16.3 g of potassium carbonate in 150 ml of methyl ethyl ketone for 15 h. The mixture is subjected to extractive work-up.</p>
      <p id="p-00114-en" num="0099">The crude product is purified by chromatography (eluent: n-heptane/MTB 4/1) and recrystallised from heptane.</p>
      <p id="p-00115-en" num="0100">White crystals.</p>
      <heading id="h-00011-en" level="2">Step 7</heading>
      <p id="p-00116-en" num="0101">
        <chemistry id="chem-00021-en" num="00022">
          <img id="img-00021-en" he="39.79mm" wi="75.86mm" alt="embedded image" img-content="chem" file="US20150259602A1_00022.PNG" img-format="png" original="US20150259602A1-20150917-C00022.TIF" />
        </chemistry>
      </p>
      <p id="p-00117-en" num="0102">17.3 g of 4,6-difluoro-3-propyloxydibenzofuran are initially introduced in 250 ml of THF, and 33 g of 15% BuLi soln. in hexane are added dropwise at â60 to â75Â° C. The mixture is stirred for a further 2 h. A solution of 7.9 g of trimethyl borate in 20 ml of THF is then added at â75 to â60Â° C. After a further 30 min at â70Â° C., the reaction mixture is allowed to warm to RT, and the batch is slowly hydrolysed using a mixture of 10 g of glacial acetic acid and 12 ml of water. 16 g of 30% hydrogen peroxide are subsequently added dropwise at such a rate that the temperature does not exceed 45Â° C.</p>
      <p id="p-00118-en" num="0103">The mixture is stirred at RT for a further 12 h and subjected to extractive work-up.</p>
      <p id="p-00119-en" num="0104">The crude product is purified by chromatography (eluent: n-heptane/MTB 3/1).</p>
      <p id="p-00120-en" num="0105">Yield 9.9 g. White crystals.</p>
      <heading id="h-00012-en" level="2">Step 8</heading>
      <p id="p-00121-en" num="0106">
        <chemistry id="chem-00022-en" num="00023">
          <img id="img-00022-en" he="43.10mm" wi="75.86mm" alt="embedded image" img-content="chem" file="US20150259602A1_00023.PNG" img-format="png" original="US20150259602A1-20150917-C00023.TIF" />
        </chemistry>
      </p>
      <p id="p-00122-en" num="0107">7.1 g of 4,6-difluoro-7-propoxydibenzofuran-3-ol are boiled under reflux with 7 g of n-butyl bromide and 5.3 g of potassium carbonate in 65 ml of methyl ethyl ketone for 5 h. The mixture is subjected to extractive work-up.</p>
      <p id="p-00123-en" num="0108">The crude product is purified by chromatography (eluent: n-heptane/chlorobutane 2/1) and recrystallised from heptane.</p>
      <p id="p-00124-en" num="0109">Yield 7.9 g. White crystals.</p>
      <p id="p-00125-en" num="0110">Phases: C 68 I (m.p. 68Â° C., cf. also table).</p>
      <p id="p-00126-en" num="0111">The following compounds are prepared analogously to Example 1:</p>
      <p id="p-00127-en" num="0000">
        <chemistry id="chem-00023-en" num="00024">
          <img id="img-00023-en" he="15.66mm" wi="53.93mm" alt="embedded image" img-content="chem" file="US20150259602A1_00024.PNG" img-format="png" original="US20150259602A1-20150917-C00024.TIF" />
        </chemistry>
      </p>
      <p id="p-00128-en" num="0112">The radicals R<sup>1/2 </sup>are straight-chain, i.e. unbranched, unless indicated otherwise. The substance data are given in Table 1.</p>
      <p id="p-00129-en" num="0000">
        <tables id="tables-00001-en" num="00001">
          <table frame="none" colsep="0" rowsep="0" pgwide="1">
            <tgroup cols="7" colsep="0" rowsep="0" align="left">
              <colspec colname="1" colwidth="35pt" align="left" />
              <colspec colname="2" colwidth="77pt" align="left" />
              <colspec colname="3" colwidth="28pt" align="center" />
              <colspec colname="4" colwidth="21pt" align="center" />
              <colspec colname="5" colwidth="21pt" align="center" />
              <colspec colname="6" colwidth="35pt" align="center" />
              <colspec colname="7" colwidth="42pt" align="center" />
              <thead>
                <row>
                  <entry namest="1" nameend="7" rowsep="1">TABLE 1</entry>
                </row>
                <row>
                  <entry namest="1" nameend="7" align="center" rowsep="1" />
                </row>
                <row>
                  <entry />
                  <entry />
                  <entry>M.p.</entry>
                  <entry />
                  <entry />
                  <entry>Î³<sub>1</sub></entry>
                  <entry />
                </row>
                <row>
                  <entry>R<sup>1</sup></entry>
                  <entry>R<sup>2</sup></entry>
                  <entry>[Â° C.]</entry>
                  <entry>ÎÎµ</entry>
                  <entry>În</entry>
                  <entry>[mPa Â· s]</entry>
                  <entry>Cl.p. [Â° C.]</entry>
                </row>
                <row>
                  <entry namest="1" nameend="7" align="center" rowsep="1" />
                </row>
              </thead>
              <tbody valign="top">
                <row>
                  <entry />
                </row>
              </tbody>
            </tgroup>
            <tgroup cols="7" colsep="0" rowsep="0" align="left">
              <colspec colname="1" colwidth="35pt" align="left" />
              <colspec colname="2" colwidth="77pt" align="left" />
              <colspec colname="3" colwidth="28pt" align="char" char="." />
              <colspec colname="4" colwidth="21pt" align="char" char="." />
              <colspec colname="5" colwidth="21pt" align="char" char="." />
              <colspec colname="6" colwidth="35pt" align="char" char="." />
              <colspec colname="7" colwidth="42pt" align="char" char="." />
              <tbody valign="top">
                <row>
                  <entry>âCH<sub>3</sub></entry>
                  <entry>âCH<sub>3</sub></entry>
                  <entry />
                  <entry />
                  <entry />
                  <entry />
                  <entry />
                </row>
                <row>
                  <entry>âCH<sub>3</sub></entry>
                  <entry>âC<sub>2</sub>H<sub>5</sub></entry>
                  <entry>119</entry>
                </row>
                <row>
                  <entry>âCH<sub>3</sub></entry>
                  <entry>âC<sub>3</sub>H<sub>7</sub></entry>
                  <entry>93</entry>
                  <entry>â15</entry>
                  <entry>0.193</entry>
                  <entry>149</entry>
                  <entry>59</entry>
                </row>
                <row>
                  <entry>âCH<sub>3</sub></entry>
                  <entry>âC<sub>4</sub>H<sub>9</sub></entry>
                  <entry>79</entry>
                  <entry>â13</entry>
                  <entry>0.191</entry>
                  <entry>144</entry>
                  <entry>60</entry>
                </row>
                <row>
                  <entry>âCH<sub>3</sub></entry>
                  <entry>âC<sub>5</sub>H<sub>11</sub></entry>
                  <entry>79</entry>
                  <entry>â14</entry>
                  <entry>0.185</entry>
                  <entry>144</entry>
                  <entry>46</entry>
                </row>
                <row>
                  <entry>âCH<sub>3</sub></entry>
                  <entry>âC<sub>6</sub>H<sub>13</sub></entry>
                </row>
                <row>
                  <entry>âC<sub>2</sub>H<sub>5</sub></entry>
                  <entry>âC<sub>2</sub>H<sub>5</sub></entry>
                </row>
                <row>
                  <entry>âC<sub>2</sub>H<sub>5</sub></entry>
                  <entry>âC<sub>3</sub>H<sub>7</sub></entry>
                  <entry>85</entry>
                  <entry>â15</entry>
                  <entry>0.189</entry>
                  <entry>128</entry>
                  <entry>66</entry>
                </row>
                <row>
                  <entry>âC<sub>2</sub>H<sub>5</sub></entry>
                  <entry>âC<sub>4</sub>H<sub>9</sub></entry>
                  <entry>77</entry>
                  <entry>â14</entry>
                  <entry>0.189</entry>
                  <entry>116</entry>
                  <entry>62</entry>
                </row>
                <row>
                  <entry>âC<sub>2</sub>H<sub>5</sub></entry>
                  <entry>âCH<sub>2</sub>CH(CH<sub>3</sub>)<sub>2</sub></entry>
                  <entry>90</entry>
                  <entry>â14</entry>
                  <entry>0.183</entry>
                  <entry>152</entry>
                  <entry>55</entry>
                </row>
                <row>
                  <entry>âC<sub>2</sub>H<sub>5</sub></entry>
                  <entry>â(CH<sub>2</sub>)<sub>2</sub>CHâCH<sub>2</sub></entry>
                  <entry>87</entry>
                  <entry>â14</entry>
                  <entry>0.196</entry>
                  <entry>102</entry>
                  <entry>51</entry>
                </row>
                <row>
                  <entry>âC<sub>2</sub>H<sub>5</sub></entry>
                  <entry>â(CH<sub>2</sub>)<sub>2</sub>CH(CH<sub>3</sub>)<sub>2</sub></entry>
                  <entry>90</entry>
                  <entry>â14</entry>
                  <entry>0.179</entry>
                  <entry>108</entry>
                  <entry>41</entry>
                </row>
                <row>
                  <entry>âC<sub>2</sub>H<sub>5</sub></entry>
                  <entry>âC<sub>5</sub>H<sub>11</sub></entry>
                  <entry>57</entry>
                  <entry>â14</entry>
                  <entry>0.181</entry>
                  <entry>119</entry>
                  <entry>59</entry>
                </row>
                <row>
                  <entry>âC<sub>2</sub>H<sub>5</sub></entry>
                  <entry>âC<sub>6</sub>H<sub>13</sub></entry>
                  <entry>68</entry>
                  <entry>â13</entry>
                  <entry>0.180</entry>
                  <entry>131</entry>
                  <entry>61</entry>
                </row>
                <row>
                  <entry>âC<sub>2</sub>H<sub>5</sub></entry>
                  <entry>â(CH<sub>2</sub>)<sub>3</sub>CH(CH<sub>3</sub>)<sub>2</sub></entry>
                  <entry>56</entry>
                  <entry>â13</entry>
                  <entry>0.167</entry>
                  <entry>144</entry>
                  <entry>51</entry>
                </row>
                <row>
                  <entry>âC<sub>3</sub>H<sub>7</sub></entry>
                  <entry>âC<sub>3</sub>H<sub>7</sub></entry>
                  <entry>75</entry>
                  <entry>â14</entry>
                  <entry>0.193</entry>
                  <entry>123</entry>
                  <entry>68</entry>
                </row>
                <row>
                  <entry>âC<sub>3</sub>H<sub>7</sub></entry>
                  <entry>âC<sub>4</sub>H<sub>9</sub></entry>
                  <entry>68</entry>
                  <entry>â13</entry>
                  <entry>0.192</entry>
                  <entry>115</entry>
                  <entry>63</entry>
                </row>
                <row>
                  <entry>âC<sub>3</sub>H<sub>7</sub></entry>
                  <entry>âC<sub>5</sub>H<sub>11</sub></entry>
                  <entry>63</entry>
                  <entry>â13</entry>
                  <entry>0.176</entry>
                  <entry>104</entry>
                  <entry>58</entry>
                </row>
                <row>
                  <entry>âC<sub>3</sub>H<sub>7</sub></entry>
                  <entry>âC<sub>6</sub>H<sub>13</sub></entry>
                  <entry>69</entry>
                  <entry>â13</entry>
                  <entry>0.171</entry>
                  <entry>125</entry>
                  <entry>61</entry>
                </row>
                <row>
                  <entry>âC<sub>4</sub>H<sub>9</sub></entry>
                  <entry>âC<sub>4</sub>H<sub>9</sub></entry>
                  <entry>87</entry>
                  <entry>â12</entry>
                  <entry>0.184</entry>
                  <entry>73</entry>
                  <entry>62</entry>
                </row>
                <row>
                  <entry>âC<sub>4</sub>H<sub>9</sub></entry>
                  <entry>âC<sub>5</sub>H<sub>11</sub></entry>
                  <entry>76</entry>
                  <entry>â12</entry>
                  <entry>0.181</entry>
                  <entry>111</entry>
                  <entry>59</entry>
                </row>
                <row>
                  <entry>âC<sub>4</sub>H<sub>9</sub></entry>
                  <entry>â(CH<sub>2</sub>)<sub>2</sub>CHâCHCH<sub>3</sub>*<sup>)</sup></entry>
                  <entry>65</entry>
                  <entry>â13</entry>
                  <entry>0.187</entry>
                  <entry>116</entry>
                  <entry>36</entry>
                </row>
                <row>
                  <entry>âC<sub>4</sub>H<sub>9</sub></entry>
                  <entry>âC<sub>6</sub>H<sub>13</sub></entry>
                </row>
                <row>
                  <entry>âC<sub>5</sub>H<sub>11</sub></entry>
                  <entry>âCF<sub>3</sub></entry>
                  <entry>64</entry>
                  <entry>â4</entry>
                  <entry>0.132</entry>
                  <entry>73</entry>
                  <entry>-24</entry>
                </row>
                <row>
                  <entry>âC<sub>5</sub>H<sub>11</sub></entry>
                  <entry>âC<sub>5</sub>H<sub>11</sub></entry>
                </row>
                <row>
                  <entry>âC<sub>5</sub>H<sub>11</sub></entry>
                  <entry>âC<sub>6</sub>H<sub>13</sub></entry>
                </row>
                <row>
                  <entry namest="1" nameend="7" align="center" rowsep="1" />
                </row>
                <row>
                  <entry namest="1" nameend="7" align="left" id="entry-00001-en">*<sup>)</sup>trans isomer</entry>
                </row>
              </tbody>
            </tgroup>
          </table>
        </tables>
      </p>
      <p id="p-00130-en" num="0113">The following compounds are prepared analogously to Example 1 and Scheme 2:</p>
      <p id="p-00131-en" num="0000">
        <chemistry id="chem-00024-en" num="00025">
          <img id="img-00024-en" he="15.66mm" wi="48.34mm" alt="embedded image" img-content="chem" file="US20150259602A1_00025.PNG" img-format="png" original="US20150259602A1-20150917-C00025.TIF" />
        </chemistry>
      </p>
      <p id="p-00132-en" num="0114">The radicals R<sup>1/2 </sup>are straight-chain, i.e. unbranched, unless indicated otherwise. The substance data are given in Table 2.</p>
      <p id="p-00133-en" num="0000">
        <tables id="tables-00002-en" num="00002">
          <table frame="none" colsep="0" rowsep="0" pgwide="1">
            <tgroup cols="7" colsep="0" rowsep="0" align="left">
              <colspec colname="1" colwidth="91pt" align="left" />
              <colspec colname="2" colwidth="77pt" align="left" />
              <colspec colname="3" colwidth="21pt" align="center" />
              <colspec colname="4" colwidth="21pt" align="center" />
              <colspec colname="5" colwidth="21pt" align="center" />
              <colspec colname="6" colwidth="35pt" align="center" />
              <colspec colname="7" colwidth="21pt" align="center" />
              <thead>
                <row>
                  <entry namest="1" nameend="7" rowsep="1">TABLE 2</entry>
                </row>
                <row>
                  <entry namest="1" nameend="7" align="center" rowsep="1" />
                </row>
                <row>
                  <entry />
                  <entry />
                  <entry>M.p.</entry>
                  <entry />
                  <entry />
                  <entry>Î³<sub>1</sub></entry>
                  <entry>Cl.p.</entry>
                </row>
                <row>
                  <entry>R<sup>1</sup></entry>
                  <entry>R<sup>2</sup></entry>
                  <entry>[Â° C.]</entry>
                  <entry>ÎÎµ</entry>
                  <entry>În</entry>
                  <entry>[mPa Â· s]</entry>
                  <entry>[Â° C.]</entry>
                </row>
                <row>
                  <entry namest="1" nameend="7" align="center" rowsep="1" />
                </row>
              </thead>
              <tbody valign="top">
                <row>
                  <entry />
                </row>
              </tbody>
            </tgroup>
            <tgroup cols="7" colsep="0" rowsep="0" align="left">
              <colspec colname="1" colwidth="91pt" align="left" />
              <colspec colname="2" colwidth="77pt" align="left" />
              <colspec colname="3" colwidth="21pt" align="char" char="." />
              <colspec colname="4" colwidth="21pt" align="char" char="." />
              <colspec colname="5" colwidth="21pt" align="char" char="." />
              <colspec colname="6" colwidth="35pt" align="char" char="." />
              <colspec colname="7" colwidth="21pt" align="char" char="." />
              <tbody valign="top">
                <row>
                  <entry>âCH<sub>3</sub></entry>
                  <entry>âCH<sub>3</sub></entry>
                  <entry />
                  <entry />
                  <entry />
                  <entry />
                  <entry />
                </row>
                <row>
                  <entry>âCH<sub>3</sub></entry>
                  <entry>âC<sub>2</sub>H<sub>5</sub></entry>
                  <entry>100</entry>
                  <entry>â10</entry>
                  <entry>0.197</entry>
                  <entry>75</entry>
                  <entry>45</entry>
                </row>
                <row>
                  <entry>âCH<sub>3</sub></entry>
                  <entry>âC<sub>3</sub>H<sub>7</sub></entry>
                  <entry>102</entry>
                  <entry>â10</entry>
                  <entry>0.187</entry>
                  <entry>90</entry>
                  <entry>39</entry>
                </row>
                <row>
                  <entry>âCH<sub>3</sub></entry>
                  <entry>âC<sub>4</sub>H<sub>9</sub></entry>
                  <entry>82</entry>
                  <entry>â9</entry>
                  <entry>0.183</entry>
                  <entry>84</entry>
                  <entry>35</entry>
                </row>
                <row>
                  <entry>âCH<sub>3</sub></entry>
                  <entry>âC<sub>5</sub>H<sub>11</sub></entry>
                  <entry>74</entry>
                  <entry>â9</entry>
                  <entry>0.172</entry>
                  <entry>89</entry>
                  <entry>28</entry>
                </row>
                <row>
                  <entry>âCH<sub>3</sub></entry>
                  <entry>âC<sub>6</sub>H<sub>13</sub></entry>
                  <entry>61</entry>
                  <entry>â9</entry>
                  <entry>0.170</entry>
                  <entry>98</entry>
                  <entry>26</entry>
                </row>
                <row>
                  <entry>âC<sub>2</sub>H<sub>5</sub></entry>
                  <entry>âCH<sub>3</sub></entry>
                </row>
                <row>
                  <entry>âC<sub>2</sub>H<sub>5</sub></entry>
                  <entry>âC<sub>2</sub>H<sub>5</sub></entry>
                  <entry>60</entry>
                  <entry>â9</entry>
                  <entry>0.182</entry>
                  <entry>65</entry>
                  <entry>16</entry>
                </row>
                <row>
                  <entry>âC<sub>2</sub>H<sub>5</sub></entry>
                  <entry>âC<sub>3</sub>H<sub>7</sub></entry>
                </row>
                <row>
                  <entry>âC<sub>2</sub>H<sub>5</sub></entry>
                  <entry>âC<sub>4</sub>H<sub>9</sub></entry>
                </row>
                <row>
                  <entry>âC<sub>2</sub>H<sub>5</sub></entry>
                  <entry>âCH<sub>2</sub>CH(CH<sub>3</sub>)<sub>2</sub></entry>
                </row>
                <row>
                  <entry>âC<sub>2</sub>H<sub>5</sub></entry>
                  <entry>â(CH<sub>2</sub>)<sub>2</sub>CHâCH<sub>2</sub></entry>
                </row>
                <row>
                  <entry>âC<sub>2</sub>H<sub>5</sub></entry>
                  <entry>â(CH<sub>2</sub>)<sub>2</sub>CH(CH<sub>3</sub>)<sub>2</sub></entry>
                </row>
                <row>
                  <entry>âC<sub>2</sub>H<sub>5</sub></entry>
                  <entry>âC<sub>5</sub>H<sub>11</sub></entry>
                </row>
                <row>
                  <entry>âC<sub>2</sub>H<sub>5</sub></entry>
                  <entry>âC<sub>6</sub>H<sub>13</sub></entry>
                </row>
                <row>
                  <entry>âC<sub>2</sub>H<sub>5</sub></entry>
                  <entry>â(CH<sub>2</sub>)<sub>3</sub>CH(CH<sub>3</sub>)<sub>2</sub></entry>
                </row>
                <row>
                  <entry>âC<sub>3</sub>H<sub>7</sub></entry>
                  <entry>âCH<sub>3</sub></entry>
                </row>
                <row>
                  <entry>âC<sub>3</sub>H<sub>7</sub></entry>
                  <entry>âC<sub>2</sub>H<sub>5</sub></entry>
                  <entry>63</entry>
                  <entry>â10</entry>
                  <entry>0.177</entry>
                  <entry>74</entry>
                  <entry>9</entry>
                </row>
                <row>
                  <entry>âC<sub>3</sub>H<sub>7</sub></entry>
                  <entry>âC<sub>3</sub>H<sub>7</sub></entry>
                  <entry>54</entry>
                  <entry>â8</entry>
                  <entry>0.174</entry>
                  <entry>72</entry>
                  <entry>7</entry>
                </row>
                <row>
                  <entry>âC<sub>3</sub>H<sub>7</sub></entry>
                  <entry>âC<sub>4</sub>H<sub>9</sub></entry>
                  <entry>65</entry>
                  <entry>â8</entry>
                  <entry>0.167</entry>
                  <entry>67</entry>
                  <entry>8</entry>
                </row>
                <row>
                  <entry>âC<sub>3</sub>H<sub>7</sub></entry>
                  <entry>â(CH<sub>2</sub>)<sub>2</sub>CHâCH<sub>2</sub></entry>
                  <entry>50</entry>
                  <entry>â8</entry>
                  <entry>0.171</entry>
                  <entry>55</entry>
                  <entry>-6</entry>
                </row>
                <row>
                  <entry>âC<sub>3</sub>H<sub>7</sub></entry>
                  <entry>âC<sub>5</sub>H<sub>11</sub></entry>
                </row>
                <row>
                  <entry>âC<sub>3</sub>H<sub>7</sub></entry>
                  <entry>âC<sub>6</sub>H<sub>13</sub></entry>
                </row>
                <row>
                  <entry>âC<sub>4</sub>H<sub>9</sub></entry>
                  <entry>âCH<sub>3</sub></entry>
                </row>
                <row>
                  <entry>âC<sub>4</sub>H<sub>9</sub></entry>
                  <entry>âC<sub>2</sub>H<sub>5</sub></entry>
                  <entry>56</entry>
                  <entry>â9</entry>
                  <entry>0.172</entry>
                  <entry>83</entry>
                  <entry>5</entry>
                </row>
                <row>
                  <entry>âC<sub>4</sub>H<sub>9</sub></entry>
                  <entry>âC<sub>3</sub>H<sub>7</sub></entry>
                </row>
                <row>
                  <entry>â(CH<sub>2</sub>)<sub>2</sub>âCHâCH<sub>2</sub></entry>
                  <entry>âC<sub>2</sub>H<sub>5</sub></entry>
                  <entry>68</entry>
                  <entry>â9</entry>
                  <entry>0.188</entry>
                  <entry>79</entry>
                  <entry>17</entry>
                </row>
                <row>
                  <entry>âC<sub>4</sub>H<sub>9</sub></entry>
                  <entry>âC<sub>4</sub>H<sub>9</sub></entry>
                </row>
                <row>
                  <entry>âC<sub>4</sub>H<sub>9</sub></entry>
                  <entry>âC<sub>5</sub>H<sub>11</sub></entry>
                </row>
                <row>
                  <entry>âC<sub>4</sub>H<sub>9</sub></entry>
                  <entry>â(CH<sub>2</sub>)<sub>2</sub>CHâCHCH<sub>3</sub>*<sup>)</sup></entry>
                </row>
                <row>
                  <entry>âC<sub>4</sub>H<sub>9</sub></entry>
                  <entry>âC<sub>6</sub>H<sub>13</sub></entry>
                </row>
                <row>
                  <entry>âC<sub>5</sub>H<sub>11</sub></entry>
                  <entry>âCH<sub>3</sub></entry>
                </row>
                <row>
                  <entry>âC<sub>5</sub>H<sub>11</sub></entry>
                  <entry>âC<sub>2</sub>H<sub>5</sub></entry>
                  <entry>60</entry>
                  <entry>â9</entry>
                  <entry>0.177</entry>
                  <entry>88</entry>
                  <entry>13</entry>
                </row>
                <row>
                  <entry>â(CH<sub>2</sub>)<sub>2</sub>âCHâCHâCH<sub>3</sub>*<sup>)</sup></entry>
                  <entry>âC<sub>2</sub>H<sub>5</sub></entry>
                  <entry>90</entry>
                  <entry>â10</entry>
                  <entry>0.193</entry>
                  <entry>94</entry>
                  <entry>49</entry>
                </row>
                <row>
                  <entry>âC<sub>5</sub>H<sub>11</sub></entry>
                  <entry>âC<sub>3</sub>H<sub>7</sub></entry>
                </row>
                <row>
                  <entry>âC<sub>5</sub>H<sub>11</sub></entry>
                  <entry>âC<sub>4</sub>H<sub>9</sub></entry>
                  <entry>64</entry>
                  <entry>â8</entry>
                  <entry>0.162</entry>
                  <entry>73</entry>
                  <entry>11</entry>
                </row>
                <row>
                  <entry>âC<sub>5</sub>H<sub>11</sub></entry>
                  <entry>â(CH<sub>2</sub>)<sub>2</sub>CHâCH<sub>2</sub></entry>
                  <entry>70</entry>
                  <entry>â8</entry>
                  <entry>0.165</entry>
                  <entry>71</entry>
                  <entry>-2</entry>
                </row>
                <row>
                  <entry>âC<sub>5</sub>H<sub>11</sub></entry>
                  <entry>âC<sub>6</sub>H<sub>13</sub></entry>
                </row>
                <row>
                  <entry namest="1" nameend="7" align="center" rowsep="1" />
                </row>
                <row>
                  <entry namest="1" nameend="7" align="left" id="entry-00002-en">*<sup>)</sup>trans isomer</entry>
                </row>
              </tbody>
            </tgroup>
          </table>
        </tables>
      </p>
      <p id="p-00134-en" num="0115">The following compounds are prepared analogously to Example 1 and Scheme 3:</p>
      <p id="p-00135-en" num="0000">
        <chemistry id="chem-00025-en" num="00026">
          <img id="img-00025-en" he="15.66mm" wi="42.67mm" alt="embedded image" img-content="chem" file="US20150259602A1_00026.PNG" img-format="png" original="US20150259602A1-20150917-C00026.TIF" />
        </chemistry>
      </p>
      <p id="p-00136-en" num="0116">The radicals R<sup>1/2 </sup>are straight-chain, i.e. unbranched, unless indicated otherwise. The substance data are given in Table 3.</p>
      <p id="p-00137-en" num="0000">
        <tables id="tables-00003-en" num="00003">
          <table frame="none" colsep="0" rowsep="0" pgwide="1">
            <tgroup cols="7" colsep="0" rowsep="0" align="left">
              <colspec colname="1" colwidth="70pt" align="left" />
              <colspec colname="2" colwidth="77pt" align="left" />
              <colspec colname="3" colwidth="21pt" align="center" />
              <colspec colname="4" colwidth="14pt" align="center" />
              <colspec colname="5" colwidth="21pt" align="center" />
              <colspec colname="6" colwidth="35pt" align="center" />
              <colspec colname="7" colwidth="21pt" align="center" />
              <thead>
                <row>
                  <entry namest="1" nameend="7" rowsep="1">TABLE 3</entry>
                </row>
                <row>
                  <entry namest="1" nameend="7" align="center" rowsep="1" />
                </row>
                <row>
                  <entry />
                  <entry />
                  <entry>M.p.</entry>
                  <entry />
                  <entry />
                  <entry>Î³<sub>1</sub></entry>
                  <entry>Cl.p.</entry>
                </row>
                <row>
                  <entry>R<sup>1</sup></entry>
                  <entry>R<sup>2</sup></entry>
                  <entry>[Â° C.]</entry>
                  <entry>ÎÎµ</entry>
                  <entry>În</entry>
                  <entry>[mPa Â· s]</entry>
                  <entry>[Â° C.]</entry>
                </row>
                <row>
                  <entry namest="1" nameend="7" align="center" rowsep="1" />
                </row>
              </thead>
              <tbody valign="top">
                <row>
                  <entry />
                </row>
              </tbody>
            </tgroup>
            <tgroup cols="7" colsep="0" rowsep="0" align="left">
              <colspec colname="1" colwidth="70pt" align="left" />
              <colspec colname="2" colwidth="77pt" align="left" />
              <colspec colname="3" colwidth="21pt" align="char" char="." />
              <colspec colname="4" colwidth="14pt" align="char" char="." />
              <colspec colname="5" colwidth="21pt" align="char" char="." />
              <colspec colname="6" colwidth="35pt" align="char" char="." />
              <colspec colname="7" colwidth="21pt" align="char" char="." />
              <tbody valign="top">
                <row>
                  <entry>âCH<sub>3</sub></entry>
                  <entry>âCH<sub>3</sub></entry>
                  <entry />
                  <entry />
                  <entry />
                  <entry />
                  <entry />
                </row>
                <row>
                  <entry>âCH<sub>3</sub></entry>
                  <entry>âC<sub>2</sub>H<sub>5</sub></entry>
                </row>
                <row>
                  <entry>âCH<sub>3</sub></entry>
                  <entry>âC<sub>3</sub>H<sub>7</sub></entry>
                </row>
                <row>
                  <entry>âCH<sub>3</sub></entry>
                  <entry>âC<sub>4</sub>H<sub>9</sub></entry>
                </row>
                <row>
                  <entry>âCH<sub>3</sub></entry>
                  <entry>âC<sub>5</sub>H<sub>11</sub></entry>
                  <entry>63</entry>
                  <entry>â5</entry>
                  <entry>0.151</entry>
                  <entry>59</entry>
                  <entry>-20</entry>
                </row>
                <row>
                  <entry>âCH<sub>3</sub></entry>
                  <entry>âC<sub>6</sub>H<sub>13</sub></entry>
                </row>
                <row>
                  <entry>âCH<sub>3</sub></entry>
                  <entry>â(CH<sub>2</sub>)<sub>2</sub>CHâCH<sub>2</sub></entry>
                  <entry>51</entry>
                  <entry>â4</entry>
                  <entry>0.157</entry>
                  <entry>108</entry>
                  <entry>-12</entry>
                </row>
                <row>
                  <entry>âCH<sub>3</sub></entry>
                  <entry>â(CH<sub>2</sub>)<sub>2</sub>CHâCHCH<sub>3</sub>*<sup>)</sup></entry>
                  <entry>59</entry>
                  <entry>â5</entry>
                  <entry>0.181</entry>
                  <entry>100</entry>
                  <entry>10</entry>
                </row>
                <row>
                  <entry>âC<sub>2</sub>H<sub>5</sub></entry>
                  <entry>âC<sub>2</sub>H<sub>5</sub></entry>
                </row>
                <row>
                  <entry>âC<sub>2</sub>H<sub>5</sub></entry>
                  <entry>âC<sub>3</sub>H<sub>7</sub></entry>
                  <entry>42</entry>
                  <entry>â4</entry>
                  <entry>0.142</entry>
                  <entry>33</entry>
                  <entry>-57</entry>
                </row>
                <row>
                  <entry>âC<sub>2</sub>H<sub>5</sub></entry>
                  <entry>âC<sub>4</sub>H<sub>9</sub></entry>
                </row>
                <row>
                  <entry>âC<sub>2</sub>H<sub>5</sub></entry>
                  <entry>âCH<sub>2</sub>CH(CH<sub>3</sub>)<sub>2</sub></entry>
                </row>
                <row>
                  <entry>âC<sub>2</sub>H<sub>5</sub></entry>
                  <entry>â(CH<sub>2</sub>)<sub>2</sub>CHâCH<sub>2</sub></entry>
                </row>
                <row>
                  <entry>âC<sub>2</sub>H<sub>5</sub></entry>
                  <entry>â(CH<sub>2</sub>)<sub>2</sub>CH(CH<sub>3</sub>)<sub>2</sub></entry>
                </row>
                <row>
                  <entry>âC<sub>2</sub>H<sub>5</sub></entry>
                  <entry>âC<sub>5</sub>H<sub>11</sub></entry>
                </row>
                <row>
                  <entry>âC<sub>2</sub>H<sub>5</sub></entry>
                  <entry>âC<sub>6</sub>H<sub>13</sub></entry>
                </row>
                <row>
                  <entry>âC<sub>2</sub>H<sub>5</sub></entry>
                  <entry>â(CH<sub>2</sub>)<sub>3</sub>CH(CH<sub>3</sub>)<sub>2</sub></entry>
                </row>
                <row>
                  <entry>âC<sub>3</sub>H<sub>7</sub></entry>
                  <entry>âC<sub>3</sub>H<sub>7</sub></entry>
                </row>
                <row>
                  <entry>âC<sub>3</sub>H<sub>7</sub></entry>
                  <entry>âC<sub>4</sub>H<sub>9</sub></entry>
                </row>
                <row>
                  <entry>âC<sub>3</sub>H<sub>7</sub></entry>
                  <entry>â(CH<sub>2</sub>)<sub>2</sub>CHâCH<sub>2</sub></entry>
                  <entry>50</entry>
                  <entry>â4</entry>
                  <entry>0.151</entry>
                  <entry>44</entry>
                  <entry>-49</entry>
                </row>
                <row>
                  <entry>âC<sub>3</sub>H<sub>7</sub></entry>
                  <entry>âC<sub>5</sub>H<sub>11</sub></entry>
                </row>
                <row>
                  <entry>âC<sub>3</sub>H<sub>7</sub></entry>
                  <entry>âC<sub>6</sub>H<sub>13</sub></entry>
                </row>
                <row>
                  <entry>âC<sub>4</sub>H<sub>9</sub></entry>
                  <entry>âC<sub>4</sub>H<sub>9</sub></entry>
                  <entry>38</entry>
                  <entry>â5</entry>
                  <entry>0.131</entry>
                  <entry>44</entry>
                  <entry>-63</entry>
                </row>
                <row>
                  <entry>â(CH<sub>2</sub>)<sub>2</sub>âCHâCH<sub>2</sub></entry>
                  <entry>â(CH<sub>2</sub>)<sub>2</sub>CHâCH<sub>2</sub></entry>
                  <entry>60</entry>
                  <entry>â5</entry>
                  <entry>0.159</entry>
                  <entry>51</entry>
                  <entry>-36</entry>
                </row>
                <row>
                  <entry>âC<sub>4</sub>H<sub>9</sub></entry>
                  <entry>âC<sub>5</sub>H<sub>11</sub></entry>
                </row>
                <row>
                  <entry>âC<sub>4</sub>H<sub>9</sub></entry>
                  <entry>â(CH<sub>2</sub>)<sub>2</sub>CHâCHCH<sub>3</sub>*<sup>)</sup></entry>
                </row>
                <row>
                  <entry>âC<sub>4</sub>H<sub>9</sub></entry>
                  <entry>âC<sub>6</sub>H<sub>13</sub></entry>
                </row>
                <row>
                  <entry>âC<sub>5</sub>H<sub>11</sub></entry>
                  <entry>â(CH<sub>2</sub>)<sub>2</sub>CHâCH<sub>2</sub></entry>
                  <entry>35</entry>
                  <entry>â4</entry>
                  <entry>0.143</entry>
                  <entry>47</entry>
                  <entry>-41</entry>
                </row>
                <row>
                  <entry>âC<sub>5</sub>H<sub>11</sub></entry>
                  <entry>âC<sub>6</sub>H<sub>13</sub></entry>
                </row>
                <row>
                  <entry namest="1" nameend="7" align="center" rowsep="1" />
                </row>
                <row>
                  <entry namest="1" nameend="7" align="left" id="entry-00003-en">*<sup>)</sup>trans isomer</entry>
                </row>
              </tbody>
            </tgroup>
          </table>
        </tables>
      </p>
      <p id="p-00138-en" num="0117">The preceding examples can be repeated with similar success by substituting the generically or specifically described reactants and/or operating conditions of this invention for those used in the preceding examples.</p>
      <p id="p-00139-en" num="0118">From the foregoing description, one skilled in the art can easily ascertain the essential characteristics of this invention and, without departing from the spirit and scope thereof, can make various changes and modifications of the invention to adapt it to various usages and conditions.</p>
    </detailed-desc>
  </description>
  <claims id="claims_eng" lang="eng" format="original" date-changed="20150917">
    <claim num="1" id="clm-00001-en" independent="true">
      <claim-text>
        <b>1</b>. A compound of formula I:</claim-text>
      <claim-text>
        <chemistry id="chemc-00001-en" num="00027">
          <img id="imgc-00001-en" he="18.54mm" wi="69.93mm" alt="embedded image" img-content="chem" file="US20150259602A1_00027.PNG" img-format="png" original="US20150259602A1-20150917-C00027.TIF" />
        </chemistry><claim-text>in which</claim-text><claim-text>m and n are each, independently of one another, 0 or 1, and</claim-text><claim-text>R<sup>1 </sup>and R<sup>2</sup>, independently of one another, denote an alkyl radical having 1 to 15 C atoms or an alkenyl or alkynyl radical having 2 to 15 C atoms, each of which are optionally mono- or polyhalogenated.</claim-text></claim-text>
    </claim>
    <claim num="2" id="clm-00002-en">
      <claim-text>
        <b>2</b>. A compound according to <claim-ref idref="clm-00001-en">claim 1</claim-ref>, wherein the sum m+n is 1 or 2.</claim-text>
    </claim>
    <claim num="3" id="clm-00003-en">
      <claim-text>
        <b>3</b>. A compound according to <claim-ref idref="clm-00001-en">claim 1</claim-ref>, wherein
<claim-text>R<sup>1 </sup>and R<sup>2</sup>, independently of one another, denote an alkyl radical having 1 to 7 carbon atoms or an alkenyl radical having 2 to 7 carbon atoms.</claim-text></claim-text>
    </claim>
    <claim num="4" id="clm-00004-en">
      <claim-text>
        <b>4</b>. A compound according to <claim-ref idref="clm-00001-en">claim 1</claim-ref>, wherein the sum of the number of carbon atoms in R<sup>1 </sup>and R<sup>2 </sup>is 4, 5, 6, 7, 8, 9 or 10.</claim-text>
    </claim>
    <claim num="5" id="clm-00005-en">
      <claim-text>
        <b>5</b>. A compound according to <claim-ref idref="clm-00001-en">claim 1</claim-ref>, which is of formula IA, IB or IC</claim-text>
      <claim-text>
        <chemistry id="chemc-00002-en" num="00028">
          <img id="imgc-00002-en" he="73.74mm" wi="69.85mm" alt="embedded image" img-content="chem" file="US20150259602A1_00028.PNG" img-format="png" original="US20150259602A1-20150917-C00028.TIF" />
        </chemistry><claim-text>in which</claim-text><claim-text>alkyl denotes an alkyl radical having 1 to 15 carbon atoms, and R<sup>2 </sup>has the meanings as defined for the compound of formula I.</claim-text></claim-text>
    </claim>
    <claim num="6" id="clm-00006-en">
      <claim-text>
        <b>6</b>. A compound according to <claim-ref idref="clm-00001-en">claim 1</claim-ref>, which is one of the following compounds</claim-text>
      <claim-text>
        <chemistry id="chemc-00003-en" num="00029">
          <img id="imgc-00003-en" he="152.74mm" wi="75.95mm" alt="embedded image" img-content="chem" file="US20150259602A1_00029.PNG" img-format="png" original="US20150259602A1-20150917-C00029.TIF" />
        </chemistry>
        <chemistry id="chemc-00004-en" num="00030">
          <img id="imgc-00004-en" he="187.45mm" wi="74.59mm" alt="embedded image" img-content="chem" file="US20150259602A1_00030.PNG" img-format="png" original="US20150259602A1-20150917-C00030.TIF" />
        </chemistry>
      </claim-text>
    </claim>
    <claim num="7" id="clm-00007-en">
      <claim-text>
        <b>7</b>. A compound according to <claim-ref idref="clm-00001-en">claim 1</claim-ref>, wherein
<claim-text>R<sup>1 </sup>and R<sup>2</sup>, independently of one another, denote an alkyl radical having 2 to 6 carbon atoms or an alkenyl radical having 3 to 6 carbon atoms or CF<sub>3</sub>.</claim-text></claim-text>
    </claim>
    <claim num="8" id="clm-00008-en">
      <claim-text>
        <b>8</b>. A compound according <claim-ref idref="clm-00001-en">claim 1</claim-ref>, wherein m and n both denote 1.</claim-text>
    </claim>
    <claim num="9" id="clm-00009-en">
      <claim-text>
        <b>9</b>. A compound according to <claim-ref idref="clm-00001-en">claim 1</claim-ref>, wherein m=0 and n=1.</claim-text>
    </claim>
    <claim num="10" id="clm-00010-en">
      <claim-text>
        <b>10</b>. A Liquid-crystalline medium comprising at least two compounds, one of which is a compound according to <claim-ref idref="clm-00001-en">claim 1</claim-ref>.</claim-text>
    </claim>
    <claim num="11" id="clm-00011-en">
      <claim-text>
        <b>11</b>. An electro-optical display element containing a liquid-crystalline medium according to <claim-ref idref="clm-00010-en">claim 10</claim-ref>.</claim-text>
    </claim>
    <claim num="12" id="clm-00012-en">
      <claim-text>
        <b>12</b>. A process for preparing a compound of formula I according to <claim-ref idref="clm-00001-en">claim 1</claim-ref>, comprising deprotonating a compound of formula (B) at position 3</claim-text>
      <claim-text>
        <chemistry id="chemc-00005-en" num="00031">
          <img id="imgc-00005-en" he="20.07mm" wi="69.93mm" alt="embedded image" img-content="chem" file="US20150259602A1_00031.PNG" img-format="png" original="US20150259602A1-20150917-C00031.TIF" />
        </chemistry><claim-text>in which m and R<sup>1 </sup>independently are defined as for the compound of formula I according to <claim-ref idref="clm-00001-en">claim 1</claim-ref>,</claim-text><claim-text>by a deprotonation reagent and converting into a compound of formula (C)</claim-text></claim-text>
      <claim-text>
        <chemistry id="chemc-00006-en" num="00032">
          <img id="imgc-00006-en" he="20.07mm" wi="69.93mm" alt="embedded image" img-content="chem" file="US20150259602A1_00032.PNG" img-format="png" original="US20150259602A1-20150917-C00032.TIF" />
        </chemistry><claim-text><claim-text>in which, independently,</claim-text><claim-text>m, R<sup>1 </sup>are defined as for the compound of formula I,</claim-text><claim-text>X denotes B(OR)<sub>2</sub>, âC(OH)R or OH, and</claim-text><claim-text>R denotes an alkyl radical having 1 to 14 C atoms. </claim-text></claim-text></claim-text>
    </claim>
  </claims>
  <drawings>
    <figure num="1">
      <img he="N/A" wi="N/A" file="US20150259602A1_00001.PNG" alt="chemical image" img-content="chem" img-format="png" original="US20150259602A1-20150917-C00001.TIF" inline="yes" />
    </figure>
    <figure num="2">
      <img he="N/A" wi="N/A" file="US20150259602A1_00002.PNG" alt="chemical image" img-content="chem" img-format="png" original="US20150259602A1-20150917-C00002.TIF" inline="yes" />
    </figure>
    <figure num="3">
      <img he="N/A" wi="N/A" file="US20150259602A1_00003.PNG" alt="chemical image" img-content="chem" img-format="png" original="US20150259602A1-20150917-C00003.TIF" inline="yes" />
    </figure>
    <figure num="4">
      <img he="N/A" wi="N/A" file="US20150259602A1_00004.PNG" alt="chemical image" img-content="chem" img-format="png" original="US20150259602A1-20150917-C00004.TIF" inline="yes" />
    </figure>
    <figure num="5">
      <img he="N/A" wi="N/A" file="US20150259602A1_00005.PNG" alt="chemical image" img-content="chem" img-format="png" original="US20150259602A1-20150917-C00005.TIF" inline="yes" />
    </figure>
    <figure num="6">
      <img he="N/A" wi="N/A" file="US20150259602A1_00006.PNG" alt="chemical image" img-content="chem" img-format="png" original="US20150259602A1-20150917-C00006.TIF" inline="yes" />
    </figure>
    <figure num="7">
      <img he="N/A" wi="N/A" file="US20150259602A1_00007.PNG" alt="chemical image" img-content="chem" img-format="png" original="US20150259602A1-20150917-C00007.TIF" inline="yes" />
    </figure>
    <figure num="8">
      <img he="N/A" wi="N/A" file="US20150259602A1_00008.PNG" alt="chemical image" img-content="chem" img-format="png" original="US20150259602A1-20150917-C00008.TIF" inline="yes" />
    </figure>
    <figure num="9">
      <img he="N/A" wi="N/A" file="US20150259602A1_00009.PNG" alt="chemical image" img-content="chem" img-format="png" original="US20150259602A1-20150917-C00009.TIF" inline="yes" />
    </figure>
    <figure num="10">
      <img he="N/A" wi="N/A" file="US20150259602A1_00010.PNG" alt="chemical image" img-content="chem" img-format="png" original="US20150259602A1-20150917-C00010.TIF" inline="yes" />
    </figure>
    <figure num="11">
      <img he="N/A" wi="N/A" file="US20150259602A1_00011.PNG" alt="chemical image" img-content="chem" img-format="png" original="US20150259602A1-20150917-C00011.TIF" inline="yes" />
    </figure>
    <figure num="12">
      <img he="N/A" wi="N/A" file="US20150259602A1_00012.PNG" alt="chemical image" img-content="chem" img-format="png" original="US20150259602A1-20150917-C00012.TIF" inline="yes" />
    </figure>
    <figure num="13">
      <img he="N/A" wi="N/A" file="US20150259602A1_00013.PNG" alt="chemical image" img-content="chem" img-format="png" original="US20150259602A1-20150917-C00013.TIF" inline="yes" />
    </figure>
    <figure num="14">
      <img he="N/A" wi="N/A" file="US20150259602A1_00014.PNG" alt="chemical image" img-content="chem" img-format="png" original="US20150259602A1-20150917-C00014.TIF" inline="yes" />
    </figure>
    <figure num="15">
      <img he="N/A" wi="N/A" file="US20150259602A1_00015.PNG" alt="chemical image" img-content="chem" img-format="png" original="US20150259602A1-20150917-C00015.TIF" inline="yes" />
    </figure>
    <figure num="16">
      <img he="N/A" wi="N/A" file="US20150259602A1_00016.PNG" alt="chemical image" img-content="chem" img-format="png" original="US20150259602A1-20150917-C00016.TIF" inline="yes" />
    </figure>
    <figure num="17">
      <img he="N/A" wi="N/A" file="US20150259602A1_00017.PNG" alt="chemical image" img-content="chem" img-format="png" original="US20150259602A1-20150917-C00017.TIF" inline="yes" />
    </figure>
    <figure num="18">
      <img he="N/A" wi="N/A" file="US20150259602A1_00018.PNG" alt="chemical image" img-content="chem" img-format="png" original="US20150259602A1-20150917-C00018.TIF" inline="yes" />
    </figure>
    <figure num="19">
      <img he="N/A" wi="N/A" file="US20150259602A1_00019.PNG" alt="chemical image" img-content="chem" img-format="png" original="US20150259602A1-20150917-C00019.TIF" inline="yes" />
    </figure>
    <figure num="20">
      <img he="N/A" wi="N/A" file="US20150259602A1_00020.PNG" alt="chemical image" img-content="chem" img-format="png" original="US20150259602A1-20150917-C00020.TIF" inline="yes" />
    </figure>
    <figure num="21">
      <img he="N/A" wi="N/A" file="US20150259602A1_00021.PNG" alt="chemical image" img-content="chem" img-format="png" original="US20150259602A1-20150917-C00021.TIF" inline="yes" />
    </figure>
    <figure num="22">
      <img he="N/A" wi="N/A" file="US20150259602A1_00022.PNG" alt="chemical image" img-content="chem" img-format="png" original="US20150259602A1-20150917-C00022.TIF" inline="yes" />
    </figure>
    <figure num="23">
      <img he="N/A" wi="N/A" file="US20150259602A1_00023.PNG" alt="chemical image" img-content="chem" img-format="png" original="US20150259602A1-20150917-C00023.TIF" inline="yes" />
    </figure>
    <figure num="24">
      <img he="N/A" wi="N/A" file="US20150259602A1_00024.PNG" alt="chemical image" img-content="chem" img-format="png" original="US20150259602A1-20150917-C00024.TIF" inline="yes" />
    </figure>
    <figure num="25">
      <img he="N/A" wi="N/A" file="US20150259602A1_00025.PNG" alt="chemical image" img-content="chem" img-format="png" original="US20150259602A1-20150917-C00025.TIF" inline="yes" />
    </figure>
    <figure num="26">
      <img he="N/A" wi="N/A" file="US20150259602A1_00026.PNG" alt="chemical image" img-content="chem" img-format="png" original="US20150259602A1-20150917-C00026.TIF" inline="yes" />
    </figure>
    <figure num="27">
      <img he="N/A" wi="N/A" file="US20150259602A1_00027.PNG" alt="chemical image" img-content="chem" img-format="png" original="US20150259602A1-20150917-C00027.TIF" inline="yes" />
    </figure>
    <figure num="28">
      <img he="N/A" wi="N/A" file="US20150259602A1_00028.PNG" alt="chemical image" img-content="chem" img-format="png" original="US20150259602A1-20150917-C00028.TIF" inline="yes" />
    </figure>
    <figure num="29">
      <img he="N/A" wi="N/A" file="US20150259602A1_00029.PNG" alt="chemical image" img-content="chem" img-format="png" original="US20150259602A1-20150917-C00029.TIF" inline="yes" />
    </figure>
    <figure num="30">
      <img he="N/A" wi="N/A" file="US20150259602A1_00030.PNG" alt="chemical image" img-content="chem" img-format="png" original="US20150259602A1-20150917-C00030.TIF" inline="yes" />
    </figure>
    <figure num="31">
      <img he="N/A" wi="N/A" file="US20150259602A1_00031.PNG" alt="chemical image" img-content="chem" img-format="png" original="US20150259602A1-20150917-C00031.TIF" inline="yes" />
    </figure>
    <figure num="32">
      <img he="N/A" wi="N/A" file="US20150259602A1_00032.PNG" alt="chemical image" img-content="chem" img-format="png" original="US20150259602A1-20150917-C00032.TIF" inline="yes" />
    </figure>
  </drawings>
  <image file="US20150259602A1.PDF" type="pdf" size="736505" pages="14" />
</lexisnexis-patent-document>